date,Article Headline,Article URL,Article Text,overall_sentiment_score,overall_sentiment_label,Stock Open,Stock Close,Stock High,Stock Low,volume,num_trades,adj_close
2022-03-04,Implied Volatility Surging for Johnson & Johnson  ( JNJ )  Stock Options,https://www.zacks.com/stock/news/1877469/implied-volatility-surging-for-johnson-johnson-jnj-stock-options,Investors need to pay close attention to Johnson & Johnson (JNJ) stock based on the movements in the options market lately.,-0.205431,Somewhat-Bearish,167.64,169.48,169.86,166.85,5873083.0,82491.0,168.873384
2022-03-07,DuPont Bets On Electronics 3D Printing,https://www.forbes.com/sites/michaelmolitch-hou/2022/03/07/dupont-bets-on-electronics-3d-printing/,DuPont has acquired specialty materials company Rogers. What will it be using its electronics 3D printing materials for?,0.129264,Neutral,168.3,172.21,173.11,167.36,11148316.0,139731.0,171.395156
2022-03-08,JNJ: 5 Stocks to Buy for Stable Income in a Volatile Market,https://stocknews.com/news/jnj-pg-pep-abt-bdx-5-stocks-to-buy-for-stable-income-in-a-volatile/,"The combined concerns around looming interest rate increases, deepening supply chain disruptions and rising oil prices with increasing economic sanctions on Russia have been fostering immense stock market volatility. And if Washington and European allies cease importing oil from Russia, oil prices could skyrocket and with potentially catastrophic economic consequences worldwide.",0.100722,Neutral,171.86,168.72,173.12,168.51,10252017.0,130246.0,170.375653
2022-03-09,Worried About the Stock Market? Here Are 2 Safe Investments to Buy and Hold for Decades,https://www.fool.com/investing/2022/03/09/worried-about-the-stock-market-here-are-2-safe-inv/,These ETFs can balance stability and long-term growth.,0.000463,Neutral,170.01,169.36,170.23,167.89,6920986.0,90670.0,169.329662
2022-03-10,"Biden's COVID program faces uncertainty after funding dropped from bill, and Moderna to trial omicron-specific booster",https://www.marketwatch.com/story/bidens-covid-program-faces-uncertainty-after-funding-dropped-from-bill-and-moderna-to-trial-omicron-specific-booster-11646928381,"President Joe Biden's COVID-19 program faced some uncertainty Thursday, after U.S. lawmakers passed a massive new bill that would fund the federal government for the remainder of the fiscal year, as well as further aid Ukraine, but a last-minute snag resulted in COVID-19 money being dropped.",-0.070546,Neutral,168.56,169.66,170.15,168.075,6009926.0,71832.0,169.253252
2022-03-11,"Oracle  ( ORCL )  Q3 Earnings Miss Estimates, Revenues Up Y/Y",https://www.zacks.com/stock/news/1881022/oracle-orcl-q3-earnings-miss-estimates-revenues-up-yy,"Oracle's (ORCL) fiscal third-quarter performance benefits from upbeat cloud business on the solid adoption of OCI, cloud ERP and Autonomous Database offerings.",0.041704,Neutral,169.13,169.35,171.46,169.02,5008429.0,71534.0,170.081115
2022-03-14,QMed Innovations Featured at LogiMed 2022,https://www.prnewswire.com/news-releases/qmed-innovations-featured-at-logimed-2022-301502006.html,CEO and Founder Vic Nunes will discuss how a data-driven supply chain saves time and money in the surgical suite,0.000313,Neutral,170.68,171.69,174.12,170.35,7305335.0,92983.0,172.257299
2022-03-15,Johnson & Johnson to Host Investor Conference Call on First-Quarter Results,https://investingnews.com/johnson-johnson-to-host-investor-conference-call-on-first-quarter-results/,"Johnson & Johnson  (  NYSE: JNJ  )  will host a conference call for investors at 8:30 a.m.  (  Eastern Time  )  on Tuesday April 19 th to review first-quarter results. Joseph J. Wolk Executive Vice President and Chief Financial Officer and Jessica Moore Vice President, Investor Relations will host the call. The question and answer portion of the call will also include additional members of Johnson & Johnson's executive team.",0.336599,Somewhat-Bullish,173.33,176.14,176.52,172.55,10122115.0,118156.0,175.069861
2022-03-16,Protagonist Therapeutics Earns $25M Milestone Payment From Janssen Biotech,https://www.benzinga.com/general/biotech/22/03/26166765/protagonist-therapeutics-earns-25m-milestone-payment-from-janssen-biotech,"Protagonist Therapeutics  ( NASDAQ: PTGX )  has received a $25 million milestone payment from its collaboration with Janssen Biotech Inc, a unit of Johnson & Johnson  ( NYSE: JNJ ) .
The payment comes after the dosing of the third patient in the Phase 2b FRONTIER 1 clinical trial of PN-235  ( JNJ-77",-0.089538,Neutral,175.33,174.52,176.95,172.56,9085510.0,133278.0,173.98706
2022-03-17,The seventh edition of Sustainability Week will examine how businesses can rise to the challenge of becoming more sustainable,https://www.prnewswire.com/news-releases/the-seventh-edition-of-sustainability-week-will-examine-how-businesses-can-rise-to-the-challenge-of-becoming-more-sustainable-301505187.html,Members of the media are invited to register here,0.048534,Neutral,174.9,176.8,176.84,174.2,7199589.0,78780.0,176.322589
2022-03-18,Multinationals Continuing Sales In Russia Under Mounting Pressure To Take Stronger Action,https://www.forbes.com/sites/lisakim/2022/03/18/multinationals-continuing-sales-in-russia-under-mounting-pressure-to-take-stronger-action/,"Under a new policy outlined by Russia's Economy Ministry, companies that suspend their operations in Russia could risk having their local units taken over by managers appointed by Russian courts, and their shares could be frozen.",-0.135965,Neutral,177.0,174.84,177.0,173.66,13648351.0,97432.0,175.085394
2022-03-21,"Will Another Covid Booster Save Vaccine Stocks Moderna, BioNTech?",https://www.investors.com/news/technology/vaccine-stocks-will-another-covid-booster-be-their-saving-grace/,Vaccine Stocks: Will Another Covid Booster Be Their Saving Grace? Investor's Business Daily,-0.073371,Neutral,174.66,175.83,177.16,174.32,7418925.0,82255.0,175.803083
2022-03-22,Do You Need A Second Booster Shot? Experts Divided Amid Report White House Doesn't Have Funding To Buy Enough For All Americans,https://www.forbes.com/sites/roberthart/2022/03/22/do-you-need-a-second-booster-shot-experts-divided-amid-report-white-house-doesnt-have-funding-to-buy-enough-for-all-americans/,Pfizer and Moderna asked regulators to greenlight fourth doses of Covid vaccine amid reports of waning immunity and ahead of an anticipated uptick in omicron cases.,-0.090986,Neutral,175.83,175.0,176.37,173.91,8323077.0,92162.0,174.812954
2022-03-23,"New Biotech Startup Looks to Take On Pfizer, Moderna",https://www.thestreet.com/investing/new-biotech-startup-looks-to-take-on-pfizer-moderna,Fighting hidden coronavirus variants is like a whack-a-mole game and this company wants to try a new approach.,0.003627,Neutral,175.23,174.34,175.54,174.09,5163014.0,75081.0,174.573035
2022-03-24,FORTUNE Live Media Announces 2022 Events Schedule,https://www.prnewswire.com/news-releases/fortune-live-media-announces-2022-events-schedule-301509301.html,"FORTUNE returns to form with a robust slate of in-person, executive-level conferences",0.389581,Bullish,174.56,175.24,175.54,174.07,4877989.0,62908.0,174.854933
2022-03-25,Why Is Theravance Bio  ( TBPH )  Up 0.4% Since Last Earnings Report?,https://www.zacks.com/stock/news/1887599/why-is-theravance-bio-tbph-up-04-since-last-earnings-report,Theravance Bio (TBPH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.,-0.036941,Neutral,175.69,176.92,177.7,175.22,4780416.0,69115.0,176.636581
2022-03-28,Global Orthopedic Software Market to Garner a Revenue of USD 636.5 Million by 2030 and Grow with a CAGR of 6.6% During 2021-2030; Increasing Adoption of EMRs/EHRs and Surge in Orthopedic Disorders to Promote Market Growth,https://www.benzinga.com/pressreleases/22/03/g26321091/global-orthopedic-software-market-to-garner-a-revenue-of-usd-636-5-million-by-2030-and-grow-with-a,"New York, March  28, 2022   ( GLOBE NEWSWIRE )  -- Post the enactment of the Affordable Care Act  ( ACA ) , also known as Obamacare, in the United States on the 23rd of March 2010 by the then president of the nation, Barack Obama, the healthcare industry, not just in the nation, but on a global leve",0.012482,Neutral,176.65,177.83,178.179,176.35,10714605.0,122161.0,177.329998
2022-03-29,CDC Advises To Mix J&J Covid Vaccine With Pfizer Or Moderna Booster,https://www.forbes.com/sites/zacharysmith/2022/03/29/cdc-advises-to-mix-jj-covid-vaccine-with-pfizer-or-moderna-booster/,"Data show that following up Johnson & Johnson's vaccine with a booster of an mRNA vaccine creates a stronger immune response and lessens the risk of serious side effects, the Centers for Disease Control and Prevention said Tuesday.",0.040436,Neutral,178.62,177.74,179.4,176.8,11899693.0,165020.0,177.722754
2022-03-30,"J&J  ( JNJ )  Gets FDA Nod for HIV Jab, Cabenuva, in Adolescents",https://www.zacks.com/stock/news/1889986/jj-jnj-gets-fda-nod-for-hiv-jab-cabenuva-in-adolescents,The FDA approves Johnson & Johnson's (JNJ) Cabenuva for treating HIV-1 in virologically suppressed adolescents aged 12 years and above.,0.02032,Neutral,178.44,179.59,179.86,177.68,11765553.0,160262.0,179.092408
2022-03-31,Trauma Fixation Devices and Equipment Market Analysis 2022 By The Business Research Company,https://www.prnewswire.com/news-releases/trauma-fixation-devices-and-equipment-market-analysis-2022-by-the-business-research-company-301513999.html,"TBRC's trauma fixation devices and equipment market report gives an analysis on market sizing and forecast, regional outlook, competitive landscape, opportunities, and strategies to take.",0.026072,Neutral,179.59,177.23,180.21,176.98,11468106.0,108155.0,178.424627
2022-04-01,Vaccination after COVID improves immunity; ivermectin fails in major trial,https://www.reuters.com/business/healthcare-pharmaceuticals/vaccination-after-covid-improves-immunity-ivermectin-fails-major-trial-2022-04-01/,April 1  ( Reuters )  - The following is a summary of some recent studies on COVID-19. They include research that warrants further study to corroborate the findings and that has yet to be certified by peer review.,0.415098,Bullish,177.05,178.19,178.43,175.6,6508385.0,91592.0,177.290918
2022-04-04,"West Virginia says J&J, drugmakers caused 'tsunami' of addiction",https://www.aljazeera.com/economy/2022/4/4/west-virginia-says-jj-drugmakers-caused-tsunami-of-addiction,"West Virginia's attorney general on Monday urged a judge to hold Johnson & Johnson, Teva Pharmaceutical Industries Ltd, and AbbVie Inc's Allergan liable for causing a ""tsunami"" of opioid addiction in the state.",-0.096974,Neutral,178.19,176.47,178.19,175.52,6844081.0,93771.0,176.433837
2022-04-05,Rising Cancer Cases Steer Healthcare Nanotechnology Market Growth At A Rate of 14% As Per The Business Research Company's Healthcare Nanotechnology Global Market Report 2022,https://www.benzinga.com/pressreleases/22/04/g26479475/rising-cancer-cases-steer-healthcare-nanotechnology-market-growth-at-a-rate-of-14-as-per-the-busin,"LONDON, April  05, 2022   ( GLOBE NEWSWIRE )  -- According to The Business Research Company's research report on the healthcare nanotechnology market, increasing cancer disease cases are expected to propel the growth of the healthcare nanotechnology market. Nanotechnology is a promising mode of canc",-0.05379,Neutral,176.47,177.61,179.65,176.29,7429613.0,97767.0,178.233344
2022-04-06,"Dow Jones Falls 300 Points After Fed Minutes; Nasdaq Sell-Off Hits Nvidia, Tesla Hard",https://www.investors.com/market-trend/stock-market-today/dow-jones-holds-up-amid-health-care-strength-nasdaq-sell-off-hits-nvidia-nvda-tesla-tsla-hard/,"Dow Jones Holds Up Amid Health Care Strength; Nasdaq Sell-Off Hits Nvidia, Tesla Hard Investor's Business Daily",-0.256491,Somewhat-Bearish,179.39,182.23,182.6,178.62,10283177.0,117571.0,181.186498
2022-04-07,Stocks That Hit 52-Week Highs On Thursday,https://www.benzinga.com/news/22/04/26526399/stocks-that-hit-52-week-highs-on-thursday,"On Thursday, 75 stocks made new 52-week highs.
Interesting Highlights From Today's 52-Week Highs:
The largest company by market cap to hit a new 52-week high was UnitedHealth Group  ( NYSE:UNH ) .
The smallest company in terms of market cap to set a new 52-week high was China Jo-Jo Drugstores  ( NAS",-0.033332,Neutral,181.67,181.76,182.95,180.23,7342999.0,95761.0,181.963913
2022-04-08,"Oro, Inc. Partnership With Dunlop Protective Footwear Wins Manufacturing Leadership Award",https://www.prnewswire.com/news-releases/oro-inc-partnership-with-dunlop-protective-footwear-wins-manufacturing-leadership-award-301520629.html,"WEST HOLLYWOOD, Calif., April 8, 2022 /PRNewswire/ -- , the business application pioneer behind OroCommerce, the No.1 open-source B2B eCommerce solution, today announced its recognition by the Manufacturing Leadership Council at the industry's flagship . Oro received a prestigious Partner Award honoring its success driving growth for Dunlop Protective Footwear, the leading manufacturer of high-quality footwear for demanding applications, while Dunlop won a Collaborative Ecosystems Award for the project.",0.040863,Neutral,181.33,182.12,183.187,180.43,7113492.0,81111.0,182.126597
2022-04-11,Trial opens in Florida opioid lawsuit case against Walgreens,https://apnews.com/article/health-business-epidemics-florida-lawsuits-b1afe615bf7105819f55e8700ae0cb5f,Trial opens in Florida opioid lawsuit case against Walgreens The Associated Press - en Español,-0.086202,Neutral,183.0,179.84,184.2,179.6,5920001.0,84797.0,180.865631
2022-04-12,Can Q1 Earnings Bring Strength in Dow ETF?,https://www.zacks.com/stock/news/1897936/can-q1-earnings-bring-strength-in-dow-etf,"With some of the blue-chip companies expected to report an earnings surprise, investors should closely monitor the movement of the Dow ETF and grab an opportunity that arises from a surge in any of the 30 stocks.",-0.137418,Neutral,179.51,179.9,180.81,178.2,5935577.0,84850.0,179.909575
2022-04-13,"Antiviral Drugs Market Size To Reach USD 50.02 BN In 2030 Due to Development Of New, Improved, And More Advanced Formulations, Such As Repurposed Drugs And Drug Combination Therapies, Says Reports and Data",https://www.prnewswire.com/news-releases/antiviral-drugs-market-size-to-reach-usd-50-02-bn-in-2030-due-to-development-of-new-improved-and-more-advanced-formulations-such-as-repurposed-drugs-and-drug-combination-therapies-says-reports-and-data-301524967.html,"NEW YORK, April 13, 2022 /PRNewswire/ -- The global antiviral drugs market size is expected to reach USD 50.02 Billion in 2030 and register a revenue CAGR of 3.4% during the forecast period, according to latest report by Reports and Data. Development of new, improved, and innovative drug formulations is a key factor expected to drive market revenue growth during the forecast period. Increase in COVID-19 cases, as well as continuous availability of a robust product pipeline of antiviral drugs, are expected to support market growth revenue during the forecast period. Current approaches for developing antiviral therapies, such as repurposed drugs, have gained attention, as they investigate new routes for repurposing commercially approved or rejected pre-existing drugs to treat viral respiratory infections. Successful therapeutic options for viral infections, such as COVID-19, Human Immunodeficiency Virus  ( HIV ) , and Human Coronavirus  ( HCoV ) , currently involve two or more drug combinations, as they can postpone development of drug resistance. These approaches can help resolve outbreaks in critical situations, in a timely and cost-effective manner.",0.010688,Neutral,179.9,180.66,180.84,179.24,5617895.0,72337.0,180.267882
2022-04-14,Stocks could stay choppy as fears about the Fed overshadow earnings news,https://www.cnbc.com/2022/04/14/stocks-could-stay-choppy-as-fears-about-the-fed-overshadow-earnings-news.html,"Investors will be watching corporate earnings to see how the things they have been worrying about - interest rates, inflation and Ukraine - are impacting the bottom line.",-0.119682,Neutral,180.0,179.9,181.4,179.73,6176048.0,65565.0,180.246325
2022-04-18,Travel Stocks Like Delta Air Are Seen as Inflation Beaters,https://www.thestreet.com/investing/stocks-that-withstand-soaring-price-increases,"Meanwhile, Credit Suisse and JPMorgan offered lists of stocks that can thrive in inflationary times like the present.",-0.049824,Neutral,179.73,177.66,180.39,176.74,6300105.0,86786.0,177.992881
2022-04-19,JNJ Stock Alert: Buy Johnson & Johnson on Push to All-Time Highs?,https://www.thestreet.com/investing/buy-johnson-johnson,Johnson & Johnson stock is hitting all-time highs on earnings. Is the stock a buy?,-0.188498,Somewhat-Bearish,180.72,183.08,185.94,179.95,14371757.0,167251.0,183.378681
2022-04-20,Johnson & Johnson Whale Trades For April 20,https://www.benzinga.com/markets/options/22/04/26716803/johnson-johnson-whale-trades-for-april-20,"A whale with a lot of money to spend has taken a noticeably bearish stance on Johnson & Johnson.
Looking at options history for Johnson & Johnson  ( NYSE:JNJ )  we detected 11 strange trades.
If we consider the specifics of each trade, it is accurate to state that 45% of the investors opened trades ",0.012577,Neutral,182.24,183.89,184.32,181.9,8015745.0,102330.0,183.5397
2022-04-21,2 Charts Big Pharma Investors Need to Understand,https://www.fool.com/investing/2022/04/21/2-charts-big-pharma-investors-need-to-understand/,The industry's leaders will fight to maintain their ranking over the next few years.,-0.411305,Bearish,183.93,183.36,184.87,182.56,6933521.0,83875.0,183.628632
2022-04-22,"Market Rally Hits Resistance, Netflix Crashes: Weekly Review",https://www.investors.com/news/market-rally-hits-resistance-netflix-crashes-tesla-lockheed-united-airlines-alcoa-in-focus-weekly-review/,"Market Rally Hits Resistance, Netflix Crashes: Weekly Review Investor's Business Daily",-0.220186,Somewhat-Bearish,182.47,181.54,183.15,181.38,7975576.0,105052.0,182.141313
2022-04-25,Best Dividend Stocks To Buy Right Now? 5 For Your Watch List,https://stockmarket.com/featured/best-dividend-stocks-to-buy-right-now-5-for-your-watch-list-2022-04-25,"Should you consider dividend stocks as market volatility persists?
The post Best Dividend Stocks To Buy Right Now? 5 For Your Watch List appeared first on Stock Market News, Quotes, Charts and Financial Information | StockMarket.com.",0.02467,Neutral,182.34,186.01,186.69,182.1,11096608.0,131141.0,184.62077
2022-04-26,Check Out What Whales Are Doing With JNJ,https://www.benzinga.com/markets/options/22/04/26818083/check-out-what-whales-are-doing-with-jnj,"Someone with a lot of money to spend has taken a bearish stance on Johnson & Johnson  ( NYSE:JNJ ) .
And retail traders should know.
We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.
Whether this is an institution or just a we",0.019308,Neutral,185.1,184.68,186.57,184.1808,10137977.0,120989.0,185.54145
2022-04-27,This Could Spell Bad News for Novavax,https://www.fool.com/investing/2022/04/27/this-could-spell-bad-news-for-novavax/,Is demand running out for COVID-19 vaccines?,-0.646,Bearish,184.24,182.1,184.82,181.74,11018911.0,126039.0,182.97325
2022-04-28,"Netflix, Tesla, Twitter. Investors Have a Lot to Talk About.",https://www.fool.com/investing/2022/04/28/netflix-tesla-twitter-investors-have-a-lot-to-talk/,Plus a look at real estate investing.,0.066616,Neutral,182.25,183.46,184.5,181.92,9358902.0,100312.0,183.366117
2022-04-29,Appeals court considers paving way for Purdue Pharma deal,https://www.aljazeera.com/economy/2022/4/29/appeals-court-considers-paving-way-for-purdue-pharma-deal,At issue is whether a bankruptcy court judge has the authority to grant members of the Sackler family who own the OxyContin maker protection from civil lawsuits over the toll of opioids.,-0.053427,Neutral,182.5,180.46,182.545,180.2,8425784.0,90159.0,180.935325
2022-05-02,DaVita  ( DVA )  to Report Q1 Earnings: What's in the Offing?,https://www.zacks.com/stock/news/1913380/davita-dva-to-report-q1-earnings-whats-in-the-offing,Supply shortage along with pandemic-led incremental mortality rate is likely to have weighed on DaVita's (DVA) first-quarter top line.,0.002181,Neutral,180.47,178.64,181.41,177.03,7096621.0,94920.0,179.002847
2022-05-03,"Washington, Drug Distributors Reach $518M Settlement For Opioid Claims",https://www.benzinga.com/general/biotech/22/05/26968751/washington-drug-distributors-reach-518m-settlement-for-opioid-claims,"Washington has reached a  $518 million settlement  with drug distributors  McKesson Corporation   ( NYSE: MCK ) ,  AmerisourceBergen Corp   ( NYSE: ABC ) , and  Cardinal Health Inc   ( NYSE: CAH )  to resolve opioid-related claims.
Washington opted out of ...Full story available on Benzinga.com",-0.06173,Neutral,178.8,178.29,180.63,177.68,5863020.0,75442.0,178.774127
2022-05-04,Bavarian Nordic to Host First Quarter 2022 Results Conference Call and Webcast,https://www.globenewswire.com/news-release/2022/05/04/2435921/0/en/Bavarian-Nordic-to-Host-First-Quarter-2022-Results-Conference-Call-and-Webcast.html,"COPENHAGEN, Denmark - May 4, 2022 - Bavarian Nordic A/S  ( OMX:  BAVA )  will announce its 2022 first quarter results on Monday, May 9, 2022.",0.182907,Somewhat-Bullish,178.15,180.2,180.5,177.15,5846817.0,79996.0,179.0303
2022-05-05,Walgreens reaches $683 mln opioid settlement with Florida,https://www.reuters.com/business/healthcare-pharmaceuticals/walgreens-reaches-683-mln-opioid-settlement-with-florida-2022-05-05/,"A sign for a Walgreens store is seen in Belle Glade, Florida January 6, 2010. REUTERS/Carlos Barria/File Photo",-0.094949,Neutral,179.42,176.76,179.71,175.27,7023979.0,98940.0,176.732444
2022-05-06,"Insights on the Opioids Global Market to 2030 - Featuring Purdue Pharma, AstraZeneca and Sanofi Among Others",https://www.prnewswire.com/news-releases/insights-on-the-opioids-global-market-to-2030---featuring--purdue-pharma-astrazeneca-and-sanofi-among-others-301541652.html,"DUBLIN, May 6, 2022 /PRNewswire/ -- The ""Opioids Market by Product Type and Application: Global Opportunity Analysis and Industry Forecast, 2021-2030"" report has been added to ResearchAndMarkets.com's offering.",0.005978,Neutral,175.14,176.37,176.87,174.69,6376033.0,88980.0,175.706291
2022-05-09,"If You Invested $10,000 in Johnson & Johnson 10 Years Ago, This Is How Much You Would Have Today",https://www.fool.com/investing/2022/05/09/if-you-invested-10000-in-johnson-johnson-10-years/,This company stands the test of time and still has room for growth.,-0.039695,Neutral,175.45,177.33,178.56,174.59,7763519.0,100338.0,177.135887
2022-05-10,WMT: 5 Blue-Chip Stocks Outperforming the Market in 2022,https://stocknews.com/news/wmt-abbv-ci-ibm-jnj-5-blue-chip-stocks-outperforming-the-market-in-2022/,"The stock market has been on a rollercoaster ride this year. The Dow has declined nearly 2%, while the Nasdaq Composite has retreated approximately 4.3%. The S&P 500 declined 3.2%, to below the 4,000 mark for the first time in over a year, as investors anticipated further bad news about U.S. inflation.",0.067138,Neutral,178.23,177.09,179.18,176.5,6697959.0,95096.0,177.395432
2022-05-11,2 No-Brainer Pharma Stocks to Buy Right Now,https://www.fool.com/investing/2022/05/11/2-no-brainer-pharma-stocks-to-buy-right-now/,Bristol-Myers Squibb and Johnson & Johnson have a lot to offer investors.,0.181638,Somewhat-Bullish,175.96,176.13,178.32,175.88,6080470.0,83152.0,176.860091
2022-05-12,Pharma ETFs in Focus Post Q1 Earnings,https://www.zacks.com/stock/news/1923421/pharma-etfs-in-focus-post-q1-earnings,Many industry bigwigs reported solid results with some beating on earnings or revenues or both.,0.064239,Neutral,176.47,177.87,177.95,174.71,6835988.0,92480.0,176.727015
2022-05-13,"Some patients and physicians say it's hard to find Paxlovid, Pfizer's COVID-19 pill",https://www.marketwatch.com/story/as-11652452454,The pill has become an increasingly important tool in the nation's defense against COVID-19 as mask mandates have lifted and people have returned to their non-distanced lives.,-0.057351,Neutral,178.7,176.85,178.89,175.8028,6797453.0,78058.0,177.336454
2022-05-16,Reaction Biology Announces Expansion of Executive Leadership Team with Key Appointments in Commercial and Human Resources Functions,https://www.prnewswire.com/news-releases/reaction-biology-announces-expansion-of-executive-leadership-team-with-key-appointments-in-commercial-and-human-resources-functions-301547688.html,"MALVERN, Pa., May 16, 2022 /PRNewswire/ -- Reaction Biology ( ""Reaction"" or the ""Company"" ) , an industry- leading provider of drug discovery services, today announced the expansion of its Executive Leadership team with the appointments of Alan Findlater to the position of Chief Commercial ...",0.154397,Somewhat-Bullish,176.85,178.08,179.13,176.17,5474553.0,67759.0,177.962729
2022-05-17,Walmart Stock Alert: Buy the Earnings Dip or Steer Clear?,https://www.thestreet.com/investing/buy-or-sell-walmart-wmt-stock-earnings-pullback,Walmart stock is getting crushed after reporting earnings. Here's the must-hold support area to watch now.,-0.14914,Neutral,178.72,178.82,179.7,176.59,5685383.0,70642.0,178.385776
2022-05-18,SciSparc Reports Developing Cannabinoids Based Acute Pain Relief Alternative To Help Counter Opioid Crisis,https://www.benzinga.com/markets/psychedelics/22/05/27281400/scisparc-reports-developing-cannabinoids-based-acute-pain-relief-alternative-to-help-counter,Image provided by Unsplash This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. Pain is an integral part of the body's nervous system that tells us when to stop doing something or if we need help - but what abou,-0.053165,Neutral,178.84,175.5,179.37,175.17,7262513.0,91552.0,177.226665
2022-05-19,What Are Whales Doing With Johnson & Johnson,https://www.benzinga.com/markets/options/22/05/27306430/what-are-whales-doing-with-johnson-johnson,Someone with a lot of money to spend has taken a bullish stance on Johnson & Johnson ( NYSE:JNJ ) . And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a we,-0.029635,Neutral,174.72,173.94,174.8,172.69,6801816.0,99088.0,173.647112
2022-05-20,Global Liposome Drug Delivery Market to Garner a Revenue of USD 11977.1 Million by 2031 and Grow with a CAGR of 10.69% During 2022-2031; Surge in Prevalence of Cancer to Drive Market Growth,https://www.benzinga.com/pressreleases/22/05/g27324936/global-liposome-drug-delivery-market-to-garner-a-revenue-of-usd-11977-1-million-by-2031-and-grow-w,"New York, May 20, 2022 ( GLOBE NEWSWIRE ) -- According to the statistics by the World Health Organization, globally, one of the leading causes of death is cancer. The disease accounted for about 10 Million deaths in the year 2020. Additionally, the disease caused 1 in 6 deaths. Further, accordin",0.031408,Neutral,174.85,176.98,177.16,174.05,7432780.0,93473.0,175.728641
2022-05-23,Why Johnson & Johnson Stock Is Rising Today,https://www.fool.com/investing/2022/05/23/why-johnson-johnson-stock-is-rising-today/,An analyst foresees strong sales growth for the healthcare giant in the coming years.,0.230984,Somewhat-Bullish,177.6,179.44,179.93,177.46,7009615.0,78545.0,179.242438
2022-05-24,Spine Implants Market Players Launch 3D Printed Implants To Speed Up Recovery Time And Efficiency Of The Treatments As Per The Business Research Company's Spine Implants Global Market Report 2022,https://www.benzinga.com/pressreleases/22/05/g27375364/spine-implants-market-players-launch-3d-printed-implants-to-speed-up-recovery-time-and-efficiency-,"LONDON, May 24, 2022 ( GLOBE NEWSWIRE ) -- According to The Business Research Company's research report on the spine implants market, 3D printing technologies have become increasingly prevalent in the healthcare industry as a treatment procedure to enhance the speed and effectiveness of joint su",0.022632,Neutral,179.25,181.4,181.74,179.1,6364272.0,82290.0,180.670796
2022-05-25,US Raises Objection To Johnson & Johnson's High Cost Lawyer For Talc Bankruptcy Case: Reuters,https://www.benzinga.com/general/biotech/22/05/27396638/us-raises-objection-to-johnson-johnsons-high-cost-lawyer-for-talc-bankruptcy-case-reuters,"Johnson & Johnson ( NYSE: JNJ ) is ready to cough up an hourly rate of $2,465 in a bid to add Hogan Lovells partner Neal Katyal to its legal team for the talc liability case. The controversial bankruptcy case tries to free JNJ from potentially billions in liabilities over its talc products claimin",-0.147084,Neutral,180.53,179.62,181.55,179.06,5549633.0,76421.0,180.047381
2022-05-26,The FDA's decision on Novavax's COVID-19 vaccine could come in weeks,https://www.marketwatch.com/story/the-fdas-decision-on-novavaxs-covid-19-vaccine-could-come-in-weeks-11653578153,"The company's protein-based shot has been authorized or approved in several other countries, including the U.K. and Singapore.",-0.025099,Neutral,181.0,179.46,181.0,178.6038,6880552.0,66869.0,179.862949
2022-05-27,Knowing This Number Can Save Your Portfolio From Disaster,https://www.fool.com/investing/2022/05/27/knowing-this-number-can-save-your-portfolio-from/,"This metric can be a great help for those who are seeking stable, long-term investments.",-0.349102,Somewhat-Bearish,179.76,181.09,181.16,178.23,5833367.0,68471.0,180.22392
2022-05-31,GlobalData Plc: COVID-19 Continues to Shape the Pharma Market,https://www.globenewswire.com/news-release/2022/05/31/2453506/0/en/GlobalData-Plc-COVID-19-Continues-to-Shape-the-Pharma-Market.html,COVID-19 driving key products and companies within the biopharmaceutical industry in 2022 COVID-19 driving key products and companies within the biopharmaceutical industry in 2022,0.053774,Neutral,178.0,179.53,180.17,175.01,16141401.0,103799.0,178.989278
2022-06-01,Manufacturers In The Surgical Sealants And Adhesives Market Are Investing In Advanced Technologies To Develop Safer And More Effective Products As Per The Business Research Company's Surgical Sealants And Adhesives Global Market Report 2022,https://www.benzinga.com/pressreleases/22/06/g27503618/manufacturers-in-the-surgical-sealants-and-adhesives-market-are-investing-in-advanced-technologies,"LONDON, June 01, 2022 ( GLOBE NEWSWIRE ) -- According to The Business Research Company's research report on the surgical sealants and adhesives market, companies in the adhesives and sealants manufacturers market are investing in technologies to make advanced medical sealants and adhesives. Adva",0.046878,Neutral,179.15,177.71,179.83,175.9,5118476.0,75675.0,177.412826
2022-06-02,Here's Why You Should Retain McKesson  ( MCK )  Stock Right Now,https://www.zacks.com/stock/news/1933189/heres-why-you-should-retain-mckesson-mck-stock-right-now,McKesson (MCK) continues to benefit from strategic partnerships and strength in the Distribution Solutions segment.,0.042703,Neutral,177.74,177.15,177.81,174.5884,8598669.0,113551.0,176.000934
2022-06-03,Best Health Care Stocks To Invest In Today? 3 In Focus,https://stockmarket.com/featured/best-health-care-stocks-to-invest-in-today-3-in-focus-2022-06-03,"With all the back-and-forth in the stock market recently, investors may be looking for more defensive stocks to jump on. Should that be the case, health care stocks would be among the key groups to consider. After all, the industry produces a vast array of life-improving solutions in the form of ...",0.121589,Neutral,177.07,176.42,178.6707,176.15,3592335.0,61301.0,177.005727
2022-06-06,"Johnson & Johnson-AbbVie Partnered Lymphoma Drug Slows Disease Progression, Data Shows",https://www.benzinga.com/general/biotech/22/06/27568835/johnson-johnson-abbvie-partnered-lymphoma-drug-slows-disease-progression-data-shows,Johnson & Johnson ( NYSE: JNJ ) and AbbVie Inc ( NYSE: ABBV ) announced primary results from the Phase 3 SHINE study of Imbruvica ( ibrutinib ) plus bendamustine-rituximab ( BR ) and rituximab maintenance in older patients with newly diagnosed mantle cell lymphoma ( MCL ) . The combination,-0.051033,Neutral,177.21,176.4,178.5,175.995,5334809.0,76249.0,176.981112
2022-06-07,Comcast and Alphabet Make Goldman's Stable Growth List,https://www.thestreet.com/investing/goldman-stable-growth-stocks-comcast-alphabet-pepsico,"If you want 'quality' themes in this environment, 'we recommend owning stocks with stable growth,' Goldman says.",0.019659,Neutral,176.98,178.34,179.3,176.4,5426580.0,69483.0,177.871854
2022-06-08,BairesDev Wins Six Globees in the 17th Annual 2022 Information Technology Awards,https://www.prnewswire.com/news-releases/bairesdev-wins-six-globees-in-the-17th-annual-2022-information-technology-awards-301564323.html,"The company, which has an NPS score of 9.1 out of 10, was recognized for its client satisfaction, growth, talent, and diversity initiatives",0.262442,Somewhat-Bullish,178.1,177.28,179.45,176.8,4316334.0,63619.0,177.795871
2022-06-09,Is Johnson & Johnson A Recession-Proof Stock?,https://www.forbes.com/sites/qai/2022/06/09/is-johnson--johnson-a-recession-proof-stock/,Johnson & Johnson (JNJ) is often considered a 'safe haven' investment during recessions. Here's why.,-0.142797,Neutral,177.21,173.71,178.65,173.64,5490160.0,65999.0,175.274289
2022-06-10,NOT REAL NEWS: A look at what didn't happen this week,https://apnews.com/article/russia-ukraine-covid-health-united-states-7331a43bbdf848afba69c4e3d209eef6,"A roundup of some of the most popular but completely untrue stories and visuals of the week. None of these are legit, even though they were shared widely on social media. The Associated Press checked them out. Here are the facts: COVID vaccines do not kill more people than rifles",-0.713863,Bearish,172.17,172.55,173.97,170.6212,6592252.0,90370.0,172.616476
2022-06-13,Dow Jones Slammed; Tesla Stock Dives As Tech Gets Hammered; Bitcoin Plummets Amid Crypto Meltdown,https://www.investors.com/market-trend/stock-market-today/dow-jones-slammed-tesla-stock-dives-as-tech-gets-hammered-bitcoin-plummets-amid-crypto-meltdown/,Dow Jones Slammed. Tesla Stock Dives As Tech Gets Hammered. Bitcoin Plummets Amid Crypto Meltdown Investor's Business Daily ...,-0.220534,Somewhat-Bearish,170.08,170.81,172.25,170.0788,7851394.0,111662.0,171.154619
2022-06-14,Rune Labs gets FDA clearance to use Apple Watch to track Parkinson's symptoms | The Financial Express,https://www.financialexpress.com/healthcare/medicaldevices/rune-labs-gets-fda-clearance-to-use-apple-watch-to-track-parkinsons-symptoms/2560704/,"Apple has partnered with a range of other companies to use the Apple Watch as a health monitoring device, including a deal with Johnson & Johnson (JNJ.N) to study whether it can be used to help lower stroke risk.",0.060891,Neutral,171.06,168.19,171.11,167.26,7092625.0,97706.0,168.559341
2022-06-15,Investing in This ETF Right Now Could Make You a Millionaire Retiree,https://www.fool.com/investing/2022/06/15/investing-in-this-etf-right-now-could-make-you-a-m/,Time and consistency will get you there.,0.409985,Bullish,169.64,169.99,171.44,168.64,7621251.0,102058.0,169.890282
2022-06-16,What Layoffs At Tesla And Coinbase Mean For Investors,https://www.forbes.com/sites/qai/2022/06/16/what-layoffs-at-tesla-and-coinbase-mean-for-investors/,"After huge falls in 2022, the tech sector is looking undervalued, which could lead to opportunities for investors.",-0.156819,Somewhat-Bearish,168.4,170.08,170.21,167.41,7018520.0,99014.0,169.479896
2022-06-17,Addex  ( ADXN )  Terminates Parkinson's-Related Dyskinesia Study,https://www.zacks.com/stock/news/1940583/addex-adxn-terminates-parkinsons-related-dyskinesia-study,Addex (ADXN) terminates the phase IIb/III study evaluating dipraglurant as a potential treatment for dyskinesia associated with Parkinson's disease. Shares fall.,-0.005445,Neutral,170.63,169.46,172.2,169.24,12437163.0,94315.0,170.005097
2022-06-21,"Kellogg to split into 3; snacks, cereals, plant-based food",https://apnews.com/article/chicago-michigan-battle-creek-kellogg-co-cc6e8bb271de40337a0b8fec4a0aa011,"Snap, crackle, pop: Kellogg to split into 3 companies The Associated Press - en ...",-0.087139,Neutral,170.75,173.01,173.86,169.56,8196203.0,81274.0,172.728877
2022-06-22,10 Stocks to Buy When They're Down,https://www.kiplinger.com/investing/stocks/value-stocks/604826/stocks-to-buy-when-they-are-down,"When you buy shares of stock, you become a partner in a business. Perhaps I'm stating the obvious, but I doubt all investors see their purchases that way. Many see stocks as horses to bet on or as scorecards that tell them how their 401 ( k ) is doing.",-0.140411,Neutral,172.0,175.74,177.92,171.69,10517260.0,111835.0,176.178152
2022-06-23,Johnson & Johnson Among Leading Companies in the Depression Pipeline Products Market | Globaldata Plc,https://www.globenewswire.com/news-release/2022/06/23/2468278/0/en/Johnson-Johnson-Among-Leading-Companies-in-the-Depression-Pipeline-Products-Market-Globaldata-Plc.html,Depression is a mood disorder that causes a persistent feeling of sadness and loss of interest Depression is a mood disorder that causes a persistent feeling of sadness and loss of interest ...,0.096139,Neutral,177.0,179.66,179.815,176.52,10127713.0,93503.0,178.582774
2022-06-24,Biological E gets WHO nod to be additional facility for production of Johnson & Johnson COVID-19 vaccine | The Financial Express,https://www.financialexpress.com/healthcare/covid-19/biological-e-gets-who-nod-to-be-additional-facility-for-production-of-johnson-johnson-covid-19-vaccine/2571981/,"Recently, the Drugs Controller General of India (DCGI) approved Corbevax as a precaution dose for those aged 18 and above.",0.660959,Bullish,180.78,182.29,182.53,179.9775,9249765.0,89382.0,181.771924
2022-06-27,"Pfizer booster improved to fight omicron, as hospitalizations rise to 3-month high",https://www.marketwatch.com/story/pfizer-booster-improved-to-fight-omicron-as-hospitalizations-rise-to-3-month-high-11656345171,"Pfizer Inc. and partner BioNTech SE said the update to their COVID-19 booster shot showed a ""high immune response"" against the omicron variant, in time for an FDA meeting and as the daily average of COVID-19-related hospitalizations rose to a 3-month high.",-0.040883,Neutral,181.64,182.12,183.3506,181.5,5869033.0,76075.0,182.386156
2022-06-28,New to Dividend Stocks? Start by Buying These 3 Ultra-Safe Picks,https://www.fool.com/investing/2022/06/28/new-to-dividend-stocks-start-by-buying-these-3-ult/,These dividend stocks could undoubtedly bring you a lifetime of passive income.,0.184302,Somewhat-Bullish,182.17,176.94,182.97,176.31,9247790.0,106536.0,178.633372
2022-06-29,"The Best Stocks to Invest $5,000 in Right Now",https://www.fool.com/investing/2022/06/29/the-best-stocks-to-invest-5000-in-right-now/,They have experienced different fortunes in the stock market this year.,0.256116,Somewhat-Bullish,177.22,176.99,178.3,176.43,6371501.0,82990.0,177.318051
2022-06-30,Here's How Much You Would Have Made Owning Johnson & Johnson Stock In The Last 15 Years,https://www.benzinga.com/news/earnings/22/06/27921306/heres-how-much-you-would-have-made-owning-johnson-johnson-stock-in-the-last-15-years,"Johnson & Johnson JNJ has outperformed the market over the past 15 years by 1.01% on an annualized basis producing an average annual return of 7.22%. Currently, Johnson & Johnson has a market capitalization of $465.27 billion.",-0.017507,Neutral,176.86,177.51,178.29,175.03,10692129.0,103733.0,176.918146
2022-07-01,U.S. Government Orders Additional Monkeypox Vaccines from Bavarian Nordic,https://www.globenewswire.com/news-release/2022/07/01/2472941/0/en/U-S-Government-Orders-Additional-Monkeypox-Vaccines-from-Bavarian-Nordic.html,"COPENHAGEN, Denmark, July 1, 2022 - Bavarian Nordic A/S ( OMX: BAVA ) announced today that the U.S. Biomedical Advanced Research and Development Authority ( BARDA ) , part of the Office of the Assistant Secretary for Preparedness and Response at the U.S.",0.128442,Neutral,177.45,179.52,179.72,176.69,5451128.0,63452.0,178.445815
2022-07-05,"COVID hospitalizations dip for first time since mid-April, but daily deaths reach 2 1/2-month high",https://www.marketwatch.com/story/covid-hospitalizations-dip-for-first-time-since-mid-april-but-daily-deaths-reach-2-1-2-month-high-11657039150,"While the daily average of new COVID-19 cases have settled back into a low-100K range that has lasted for about seven weeks, hospitalizations took their first dip since mid-April and deaths ticked up to a 2 1/2-month high.",-0.206701,Somewhat-Bearish,178.83,178.14,179.125,174.61,5646587.0,80242.0,176.936001
2022-07-06,"Vertex, WWE, KO Stock Among 25 Names On IBD Breakout Stocks Index",https://www.investors.com/research/breakout-stocks-technical-analysis/ko-stock-vertex-wwe-among-25-names-on-ibd-breakout-stocks-index/,"While the market indexes remain volatile, 25 companies from a broad range of sectors earn a spot on the IBD Breakout Stocks Index. Vertex Pharmaceuticals ( VRTX ) , AbbVie ( ABBV ) and McKesson ( MCK ) make the cut among medical stocks. KO stock, CNC and WWE show the breadth of the list.",0.080917,Neutral,178.07,178.3,179.44,177.41,5302220.0,68965.0,178.253693
2022-07-07,Should You Get A Covid Booster? Here's Who Should-And How.,https://www.forbes.com/sites/roberthart/2022/07/07/should-you-get-a-covid-booster-heres-who-should-and-how/,"It makes no sense to wait for an updated booster vaccine in fall and ""leave yourself vulnerable"" when there is lots of virus circulating, Dr. John Swartzberg, an infectious disease expert at the University of California at Berkeley, told Forbes.",-0.174495,Somewhat-Bearish,177.86,178.5,179.12,177.51,5705796.0,66817.0,178.2785
2022-07-08,This is Why Johnson & Johnson  ( JNJ )  is a Great Dividend Stock,https://www.zacks.com/stock/news/1949968/this-is-why-johnson-johnson-jnj-is-a-great-dividend-stock,"Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Johnson & Johnson (JNJ) have what it takes? Let's find out.",0.068326,Neutral,178.33,178.28,179.99,177.77,3793279.0,50105.0,178.763224
2022-07-11,U.S. Secures 3.2 Million Novavax Covid Vaccines - Offering Alternative To MRNA Shots As New Variant Spreads,https://www.forbes.com/sites/brianbushard/2022/07/11/us-secures-32-million-novavax-covid-vaccines---offering-alternative-to-mrna-shots-as-new-variant-spreads/,"The vaccine, which differs from mRNA shots like Pfizer's and Moderna's, still needs FDA emergency authorization before it can be administered.",0.019182,Neutral,177.7,178.35,179.02,177.52,3606649.0,56472.0,178.343994
2022-07-12,A Strong Dollar And Looming CPI Report Appear To Be Unsettling Investors,https://www.benzinga.com/news/earnings/22/07/28037246/a-strong-dollar-and-looming-cpi-report-appear-to-be-unsettling-investors,( Tuesday Market Open ) Equity index futures were falling once again ahead of the opening bell as recession fears pushed the Cboe Market Volatility Index ( VIX ) up 3% to the 27 level and WTI crude oil futures tumbled 4.68%.,-0.109542,Neutral,177.98,175.85,178.45,175.1951,4689886.0,65795.0,176.52859
2022-07-13,DVY: 3 Defensive ETFs to Help Your Portfolio Battle a Bear Market,https://stocknews.com/news/dvy-vig-splv-3-defensive-etfs-to-help-your-portfolio-battle-a-bear/,"The S&P 500 witnessed a record worst performance in the first half of 2022 and officially entered the bear market in mid-June. The benchmark index has lost 20% year to date. Moreover, UBS recently slashed its year-end price target for the S&P 500 to 4,150, down from its previous estimate of 4,850.",0.00241,Neutral,175.66,175.44,176.33,174.5,5242082.0,75282.0,175.407398
2022-07-14,JNJ: Here's Why Every Investor Might Want to Buy Shares of JNJ,https://stocknews.com/news/jnj-mrk-nvs-zts-heres-why-every-investor-might-want-to-buy-shares-of/,JNJ: Here's Why Every Investor Might Want to Buy Shares of ...,0.286636,Somewhat-Bullish,172.53,175.68,176.01,172.2968,5311889.0,67891.0,174.944251
2022-07-15,5 takeaways from the Investing Club's 'Morning Meeting' on Friday,https://www.cnbc.com/2022/07/15/5-takeaways-from-the-investing-clubs-morning-meeting-on-friday-july-15.html,"Wall Street surged on Friday's strong retail sales, looking to put a big dent in what's been tracking as another losing week for stocks.",0.230342,Somewhat-Bullish,177.71,178.23,178.51,176.55,5670300.0,59047.0,177.856437
2022-07-18,Buy Healthcare Stocks To Beat Surprise Scourge Of Deflation,https://www.forbes.com/sites/jonmarkman/2022/07/18/buy-healthcare-stocks-to-beat-surprise-scourge-of-deflation/,"Inflation has been red hot, and consumer spending remains robust despite rising interest rates. That is yesterday's news. Investors should prepare for deflation.",-0.189703,Somewhat-Bearish,177.74,174.23,178.19,173.91,7585668.0,98248.0,175.312136
2022-07-19,The Moves to Make Now in Light of Apple's Hiring Slowdown,https://moneymorning.com/2022/07/19/the-moves-to-make-now-in-light-of-apples-hiring-slowdown/,"Yesterday, we witnessed a short burst of momentum - anchored by stronger banking earnings and improved expectations around rate hikes in July. And then... Apple Inc. ( NASDAQ: AAPL ) happened. The company announced plans to slow down hiring thanks to the ongoing fear of higher interest rates ...",0.132753,Neutral,176.33,171.69,176.75,169.88,13227538.0,155668.0,172.20116
2022-07-20,4 Analysts Takeaways From Johnson & Johnson's Quarterly Results: What Investors Need To Know,https://www.benzinga.com/analyst-ratings/analyst-color/22/07/28135168/4-analyst-takeaways-from-johnson-johnsons-quarterly-results,"Johnson & Johnson JNJ reported a 3% growth in net sales to $24.02 billion, surpassing the consensus estimate of $23.81 billion, and a 4.4% growth in adjusted earnings to $2.59 per share, beating Street expectations of $2.57 per share.",0.246895,Somewhat-Bullish,172.2,170.71,172.55,169.76,7422729.0,100746.0,171.188783
2022-07-21,"Global Positive Allosteric Modulators Market to Grow at a Significant CAGR During 2022-2031; Market to Grow on the Back of the Increasing Prevalence of Chronic Mental Disorders, Upsurge in the Geriatric Population, and Advancement in R&D",https://www.benzinga.com/pressreleases/22/07/g28154556/global-positive-allosteric-modulators-market-to-grow-at-a-significant-cagr-during-2022-2031-market,"New York, July 21, 2022 ( GLOBE NEWSWIRE ) -- As per the World Health Organization, anxiety and depressive disorders are estimated to be the most prevalent mental disorders, affecting 1 in 8 persons, or 970 million people worldwide, in 2019.",0.118894,Neutral,170.05,171.31,171.39,169.77,5692156.0,81028.0,170.794344
2022-07-22,"Market Rally Breaks Higher As Tesla, Netflix Jump On Earnings",https://www.investors.com/news/stock-market-rally-breaks-higher-as-tesla-netflix-snap-united-airlines-earnings/,"Stock Market Rally Breaks Higher. Tesla, Netflix, Snap, United Airlines Key Earnings: Weekly Review | Investor's Business Daily Investor's Business Daily ...",-0.131098,Neutral,171.595,172.12,172.49,171.06,4224204.0,59827.0,171.811226
2022-07-25,Johnson & Johnson Whale Trades For July 25,https://www.benzinga.com/markets/options/22/07/28191926/johnson-johnson-whale-trades-for-july-25,"Someone with a lot of money to spend has taken a bullish stance on Johnson & Johnson JNJ. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",0.145123,Neutral,172.12,172.46,172.975,171.72,4416657.0,60979.0,172.365999
2022-07-26,Tremor International acquires Amobee for $239M,https://www.axios.com/pro/media-deals/2022/07/26/tremor-international-amobee-acquisition,Tremor International acquires ad tech company Amobee for $239 million ...,0.213362,Somewhat-Bullish,172.56,173.68,174.98,172.49,4512627.0,63782.0,173.833661
2022-07-27,"Breast Reconstruction Market Size is projected to reach USD 790 million by 2030, growing at a CAGR of 6.12%: Straits Research",https://www.benzinga.com/pressreleases/22/07/g28227171/breast-reconstruction-market-size-is-projected-to-reach-usd-790-million-by-2030-growing-at-a-cagr-,"New York, United States, July 27, 2022 ( GLOBE NEWSWIRE ) -- Breast Reconstruction is a surgical technique that aims to make the breasts look as natural-looking as possible while redesigning and increasing their size and form.",0.081353,Neutral,172.63,173.2,174.1,171.13,4599019.0,71091.0,172.764602
2022-07-28,"Daily Biotech Pulse: GSK's Kidney Disease Drug Approved For Children, Tonix Pharma To Launch Monkeypox Vaccine Study In Kenya, Positive Effect Of Cyclerion's Schizophrenia Candidate",https://www.benzinga.com/general/biotech/22/07/28245572/daily-biotech-pulse-gsks-kidney-disease-drug-approved-for-children-tonix-pharma-to-launch-monkeyp,Here's a roundup of top developments in the biotech space over the last 24 hours: The FDA has approved GSK plc's GSK Benlysta ( belimumab ) for the treatment of children ages 5-17 with active lupus nephritis ( LN ) who are receiving standard therapy.,0.194439,Somewhat-Bullish,173.4,174.2,176.09,171.44,5513018.0,77569.0,174.21901
2022-07-29,Allergan Reaches Tentative $2.37 Billion Deal to Settle Opioid Suits,https://www.nytimes.com/2022/07/29/health/allergan-opioids-settlement.html,"If finalized, the agreement, along with a companion deal reached by Teva earlier this week, would send as much as $6.6 billion to communities harmed by the opioid epidemic.",0.01707,Neutral,173.79,174.52,174.85,172.91,6443954.0,73745.0,174.09208
2022-08-01,Innovative Platform for Tracking High-Value Medical Devices,https://www.benzinga.com/pressreleases/22/08/g28293668/innovative-platform-for-tracking-high-value-medical-devices,"San Diego, CA, Aug. 01, 2022 ( GLOBE NEWSWIRE ) -- Truepic, the leader in digital image provenance and authenticity, will work with DePuy Synthes Canada* by integrating the Truepic Vision platform seamlessly into their operations process.",0.354015,Bullish,174.17,173.91,175.155,173.5425,5433335.0,75190.0,174.229032
2022-08-02,Emergent's  ( EBS )  Q2 Earnings and Revenues Miss Estimates,https://www.zacks.com/stock/news/1962282/emergents-ebs-q2-earnings-and-revenues-miss-estimates,Emergent's (EBS) second-quarter 2022 earnings and revenues miss estimates. EBS issues fresh guidance for its CDMO services.,0.012058,Neutral,175.01,172.92,175.49,172.7,5759563.0,78657.0,173.887759
2022-08-03,FTXH: 3 Health Care ETFs You'll Want to Own When the Market Recovers,https://stocknews.com/news/ftxh-vht-pph-3-health-care-etfs-youll-want-to-own-when-the/,"As the Fed raised interest rates by 75 basis points for the second straight month in July to tame the multi-decade high inflation, recession fears have intensified. In addition, the U.S. economy contracted for the second straight quarter this year, making many analysts believe that a recession ...",0.093442,Neutral,172.55,174.59,175.26,171.77,4998404.0,71843.0,174.166772
2022-08-04,"FATE's Q2 Loss Narrower Than Expected, Pipeline in Focus",https://www.zacks.com/stock/news/1964060/fates-q2-loss-narrower-than-expected-pipeline-in-focus,FATE reports a narrower loss and higher collaboration revenues in the second quarter.,0.01675,Neutral,174.81,171.79,175.09,171.6,5641435.0,71591.0,172.521909
2022-08-05,"Official U.S. tally of new cases may be declining, but at-home testing obscures data; Novavax opens trial of vaccine for very young children",https://www.marketwatch.com/story/official-u-s-new-case-tally-may-be-declining-but-at-home-testing-obscures-data-and-novavax-starts-trial-of-vaccine-for-very-young-children-11659709680,"The daily average for new U.S. cases may have started to decline based on official numbers, but it's unclear at this time if the trend is real as so many people are testing at home and the data are not being captured.",-0.038181,Neutral,171.3,171.11,171.53,169.79,5227551.0,82414.0,170.937369
2022-08-08,Biden's Inflation Reduction Act: Investing Winners and Losers,https://www.kiplinger.com/investing/stocks/605045/bidens-inflation-reduction-act-investing-winners-and-losers,"It may still be a few weeks before President Joe Biden signs it, but it looks like the Inflation Reduction Act is about to become reality. The legislation passed the Senate, and it now awaits review by the House of Representatives, likely by next week.",0.120462,Neutral,171.3,170.2,171.48,169.4354,4618954.0,71389.0,170.468611
2022-08-09,JNJ: 2 Stocks to Buy While Their Prices Are Down,https://stocknews.com/news/jnj-cost-2-stocks-to-buy-while-their-prices-are-down/,"The stock market experienced wild swings in the first half of 2022, as evidenced by the CBOE Volatility Index's ( VIX ) 28.4% year-to-date gains. Furthermore, the stock market is expected to remain under immense pressure due to sky-high inflation, consecutive interest rate hikes, and recessionary ...",0.203358,Somewhat-Bullish,170.54,170.18,171.12,169.73,5523270.0,73773.0,170.314883
2022-08-10,"Russians buy last goods from H&M, IKEA as stores begin exit",https://www.aljazeera.com/economy/2022/8/10/russians-buy-last-goods-from-hm-ikea-as-stores-begin-exit,"Mega-retailers H&M and IKEA are unloading their stocks in Russia as they wind down their business in the country. Russians are snapping up Western fashion and furniture this week as H&M and IKEA sell off the last of their inventory in Russia, moving forward with their exit from the country after ...",0.004749,Neutral,171.02,170.67,171.24,169.53,5588529.0,75357.0,170.394249
2022-08-11,Why GSK  ( GSK )  Shares Are Plunging Today,https://www.benzinga.com/general/biotech/22/08/28458058/sanofi-gsk-pfizer-shares-shed-40b-in-market-value-heart-burn-drug-concerns-report,"Sanofi SA SNY, GSK Plc GSK, and Haleon Plc HLN have lost a combined $40 billion in market value since Tuesday's close amid litigation concerns around the recalled heartburn drug Zantac ( ranitidine ) , Bloomberg writes.",-0.040544,Neutral,168.52,167.14,169.95,166.98,9314779.0,116859.0,168.04386
2022-08-12,3 takeaways from the Investing Club's 'Morning Meeting' on Friday,https://www.cnbc.com/2022/08/12/3-takeaways-from-the-investing-clubs-morning-meeting-on-friday.html,The Investing Club hosts its 'Morning Meeting' every day at 10:20 a.m. ET.,0.026694,Neutral,167.54,165.3,167.94,165.15,14577781.0,160021.0,165.846328
2022-08-15,BZ Chart Of The Day: Johnson & Johnson Is Nearing This Key Support Level,https://www.benzinga.com/trading-ideas/long-ideas/22/08/28496886/bz-chart-of-the-day-jnj-may-soon-be-a-buy,Johnson & Johnson JNJ stock is oversold and getting close to a level that has been support in the past. Oversold refers to momentum. It means the stock has been aggressively sold so hard that it is below what would be its usual or typical trading range.,0.181478,Somewhat-Bullish,166.0,166.09,166.75,165.125,10069111.0,116507.0,166.044672
2022-08-16,"NexImmune Pauses Developing Multiple Myeloma Hopeful, Citing Competition",https://www.benzinga.com/general/biotech/22/08/28520693/neximmune-pauses-developing-multiple-myeloma-hopeful-citing-competition,"NexImmune Inc NEXI cited the competitive environment in the blood cancer space as the reason for pausing enrollment for NEXI-002 in multiple myeloma. The biotech referred to ""recent product approvals and the competitive environment in the relapsed refractory multiple myeloma space."" as the reason ...",0.156157,Somewhat-Bullish,165.86,167.57,168.2539,165.6,7439174.0,91018.0,167.169571
2022-08-17,Stocks: Winners and Losers from the Strong Dollar,https://www.kiplinger.com/investing/stocks/605095/stocks-winners-and-losers-from-the-strong-dollar,A strong dollar is a thorn in the side of U.S companies with a global footprint. Revenues earned overseas translate into fewer greenbacks here when the dollar is strengthening. And U.S. products become increasingly pricey for consumers abroad.,0.118319,Neutral,166.41,167.58,168.56,166.41,7389818.0,78481.0,167.725835
2022-08-18,Why Is Johnson & Johnson  ( JNJ )  Down 1.8% Since Last Earnings Report?,https://www.zacks.com/stock/news/1969773/why-is-johnson-johnson-jnj-down-18-since-last-earnings-report,Johnson & Johnson (JNJ) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.,0.063112,Neutral,167.68,166.77,168.3,165.93,8299770.0,69021.0,166.984247
2022-08-19,Covid Stocks Face Their Next Multibillion-Dollar Challenge,https://www.investors.com/news/technology/covid-stocks-face-their-next-challenge-and-there-are-billions-of-dollars-at-stake/,Covid Stocks Face Their Next Challenge And There Are Billions Of Dollars At Stake Investor's Business Daily ...,0.155567,Somewhat-Bullish,167.1,169.31,170.12,167.0,8119205.0,87322.0,169.004741
2022-08-22,McDonald's board member targeted by Icahn to leave in reshuffle,https://www.reuters.com/business/retail-consumer/mcdonalds-board-member-targeted-by-icahn-leave-reshuffle-2022-08-22/,"The McDonald's logo is seen outside the fast-food chain McDonald's in New York, U.S., October 22, 2019. REUTERS/Shannon Stapleton/File Photo NEW YORK, Aug 22 ( Reuters ) - A McDonald's Corp board member targeted by activist investor Carl Icahn over the company's animal welfare policies will ...",-0.132856,Neutral,168.9,167.59,168.92,167.17,5459010.0,82387.0,167.784857
2022-08-23,"Minerva  ( NERV )  Submits NDA for Schizophrenia Candidate, Stock Up",https://www.zacks.com/stock/news/1971510/minerva-nerv-submits-nda-for-schizophrenia-candidate-stock-up,Minerva's (NERV) stock surges after the company files an NDA-seeking FDA approval for its schizophrenia therapy.,-0.01226,Neutral,167.0,166.13,167.77,165.8,5555378.0,71649.0,166.316861
2022-08-24,Axsome Therapeutics  ( Finally )  Earns Approval. Here's What's Next,https://www.thestreet.com/investing/axsome-therapeutics-auvelity-approval-whats-next,The drug developer earned FDA approval for a new depression treatment. Now comes the hard part.,0.076916,Neutral,166.56,165.58,166.59,165.07,5666784.0,68100.0,165.679181
2022-08-25,J&J  ( JNJ )  Gets EU Nod for Multiple Myeloma Drug Tecvayli,https://www.zacks.com/stock/news/1972576/jj-jnj-gets-eu-nod-for-multiple-myeloma-drug-tecvayli,J&J (JNJ) gets approval for Tecvayli (teclistamab) for the treatment of relapsed and refractory multiple myeloma. This marks the first approval for Tecvayli in any country.,0.22994,Somewhat-Bullish,165.95,167.13,167.24,164.7,5665175.0,72480.0,166.055896
2022-08-26,SMMT: Should You Follow the Insider Buying in Summit Therapeutics,https://stocknews.com/news/smmt-jnj-nvs-supn-lly-should-you-follow-the-insider-buying-in-summit-therapeutics/,"Summit Therapeutics Inc. ( SMMT ) is a biopharmaceutical company that engages in the discovery, development, and commercialization of medicines to treat infectious diseases in the United States and Latin America. The company conducts clinical programs focusing on Clostridioides difficile ...",0.065259,Neutral,167.46,164.27,167.5,164.195,5648771.0,66011.0,165.510184
2022-08-29,Bristol Myers  ( BMY )  Announces Milvexian Phase II Study Results,https://www.zacks.com/stock/news/1973645/bristol-myers-bmy-announces-milvexian-phase-ii-study-results,"Bristol Myers (BMY) announces AXIOMATIC-SSP study results of milvexian, an investigational oral factor XIa inhibitor, for preventing new symptomatic ischemic stroke or new covert brain infarction.",0.152298,Somewhat-Bullish,163.47,163.0,163.84,162.02,5248540.0,82131.0,163.087554
2022-08-30,Bankruptcy Courts Are Good At Adjudicating Tort Claims,https://www.forbes.com/sites/ikebrannon/2022/08/30/bankruptcy-courts-are-good-at-adjudicating-tort-claims/,Using a bankruptcy trust to make a liability more tractable makes a lot of sense in many circumstances. Bankruptcy courts are designed to adjudicate such issues so that legitimate creditors can get compensated in a timely manner while preserving the viability of the broader business.,-0.126991,Neutral,163.3,162.43,163.54,162.03,6937061.0,74832.0,162.628242
2022-08-31,What the Strong Dollar Means for Businesses and Investors,https://www.kiplinger.com/investing/605164/what-the-strong-dollar-means-for-businesses-and-investors,"The U.S. dollar is the strongest it's been in decades, and it's showing no signs of cooling off. Given the continuing focus by financial markets on the aggressive monetary policy tightening by the Federal Reserve, the dollar's strength should continue against most foreign currencies at least ...",-0.007254,Neutral,163.23,161.34,163.55,161.27,8713326.0,76459.0,162.015848
2022-09-01,New Hampshire to get $40.5M in opioids case settlement,https://apnews.com/article/health-lawsuits-new-hampshire-opioids-1d783684501e9a4f28046a8c0f99c6a5,"CONCORD, N.H. ( AP ) - Drugmaker Johnson & Johnson has agreed to pay $40.5 million in a settlement with New Hampshire over its role in the opioid addiction crisis, days before the case was scheduled for trial, the state attorney general's office said Thursday.",0.019589,Neutral,161.49,165.34,165.5,161.48,7478930.0,93964.0,164.310994
2022-09-02,Fate Therapeutics  ( FATE )  Down 17% Since Last Earnings Report: Can It Rebound?,https://www.zacks.com/stock/news/1975955/fate-therapeutics-fate-down-17-since-last-earnings-report-can-it-rebound,Fate Therapeutics (FATE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.,0.004797,Neutral,165.86,162.74,166.2,162.01,5762816.0,81583.0,164.198513
2022-09-06,S&P 500 Vs Nasdaq 100 Vs Dow 30: Difference between indices and the divergence in returns | The Financial Express,https://www.financialexpress.com/investing-abroad/featured-stories/sampp-500-vs-nasdaq-100-vs-dow-30-difference-between-indices-and-the-divergence-in-returns/2657342/,S&P 500 Vs Nasdaq 100 Vs Dow 30: Difference between indices and the divergence in returns The Financial Express ...,0.180853,Somewhat-Bullish,163.94,163.18,166.215,162.82,7310197.0,96354.0,164.144685
2022-09-07,UM Named a 2022 Fortune Magazine Best Workplace in Advertising & Marketing™,https://www.prnewswire.com/news-releases/um-named-a-2022-fortune-magazine-best-workplace-in-advertising--marketing-301618923.html,"NEW YORK, Sept. 7, 2022 /PRNewswire/ -- UM, the network of IPG Mediabrands, has been honored by Fortune Magazine as a 2022 ""Best Workplace in Advertising & Marketing."" This highly coveted recognition honors companies that have adapted to the challenges of an ever-changing workplace through their ...",0.57835,Bullish,162.91,164.07,164.42,162.16,4520138.0,62596.0,163.694769
2022-09-08,"Global Vaginal Slings Market to Grow at a CAGR of ~15% during 2022-2031; Market to Expand on the Back of Increasing Awareness Related to Urine Inconsistency, and Growing Aged Women Population across the Globe - Kenneth Research",https://www.benzinga.com/pressreleases/22/09/g28790902/global-vaginal-slings-market-to-grow-at-a-cagr-of-15-during-2022-2031-market-to-expand-on-the-back,"New York, Sept. 08, 2022 ( GLOBE NEWSWIRE ) -- Kenneth Research has published a detailed market report on 'Global Vaginal Slings Market' for the forecast period, i.e. 2022 - 2031, which includes the following factors:",0.186662,Somewhat-Bullish,163.88,165.39,165.42,163.08,5772928.0,67535.0,164.654911
2022-09-09,"Johnson & Johnson  ( NYSE:JNJ ) , AbbVie  ( NYSE:ABBV )  - Some Breast Implant Cases Are Associated With Skin Cancer, FDA Receives Reports",https://www.benzinga.com/general/biotech/22/09/28807515/fda-receives-reports-on-breast-implant-associated-skin-cancer,"In a safety notice, the FDA has received several reports of certain cancers in the scar tissue around breast implants. The FDA learned about these reports through continual postmarket reviews of breast implants and ongoing collaboration with external stakeholders.",-0.078991,Neutral,164.99,165.71,166.2,164.3884,5488149.0,65549.0,165.546733
2022-09-12,"Apple  ( NASDAQ:AAPL ) , BYD  ( OTC:BYDDY )  - Top Financial Stories Monday, September 12: Netflix Collaborates With Assassin's Creed Maker, Gun Sales Could Soon Be Tracked Via Payment Processors, Xi Jinping To Meet Vladimir Putin In First Foreign Trip And More...",https://www.benzinga.com/general/biotech/22/09/28827654/benzinga-before-the-bell-and-other-top-financial-stories-monday-september-12,"Chinese battery maker CALB Co., a rival to companies like Contemporary Amperex Technology Co Ltd. ( CATL ) and Warren Buffett-backed BYD Co. BYDDF, has started gauging investor demand for its $2 billion Hong Kong initial public offering.",0.156086,Somewhat-Bullish,166.11,165.64,166.57,165.22,6308698.0,75253.0,165.747141
2022-09-13,"JNJ: 5 ""Strong Buy"" Health Care Stocks to Buy This Week",https://stocknews.com/news/jnj-pfe-nvo-bmy-gsk-5-strong-buy-health-care-stocks-to-buy-this-week/,"With nearly 60% of adult Americans suffering from at least one chronic disease, the healthcare sector sees significant demand. Moreover, a rise in the aging population and increased health awareness amongst the masses is boding well for the industry.",0.263369,Somewhat-Bullish,163.57,161.33,164.44,160.81,6684626.0,92005.0,162.128819
2022-09-14,"3 takeaways from Wednesday's meeting: Stay diversified, watch these stocks, why we made a trim",https://www.cnbc.com/2022/09/14/3-takeaways-from-wednesdays-meeting-stay-diversified-watch-these-stocks-why-we-made-a-trim.html,"The Investing Club holds its ""Morning Meeting"" every weekday at 10:20 a.m. ET.",0.20157,Somewhat-Bullish,162.38,164.66,165.36,162.38,9512176.0,107237.0,164.500746
2022-09-15,"J&J  ( JNJ )  Announces $5B Stock Repurchase Program, Stock Up",https://www.zacks.com/stock/news/1981008/jj-jnj-announces-5b-stock-repurchase-program-stock-up,J&J (JNJ) to buy back $5 billion worth of shares. It also reaffirms its financial guidance for 2022.,0.216494,Somewhat-Bullish,164.45,165.08,166.07,164.1,7126540.0,99113.0,165.165639
2022-09-16,Maharashtra FDA cancels manufacturing licence of J&J baby powder,https://www.business-standard.com/article/companies/maharashtra-fda-cancels-manufacturing-license-of-j-j-baby-powder-122091601339_1.html,The state government body also said that the use of the product may affect the health of the skin of newborn babies ...,-0.018537,Neutral,165.32,167.6,167.63,164.75,20143803.0,121887.0,166.971926
2022-09-19,"3 takeaways from Monday's meeting: Market needs a break to rise, some possible buys",https://www.cnbc.com/2022/09/19/3-takeaways-from-mondays-meeting-market-needs-a-break-to-rise-some-possible-buys.html,"The Investing Club holds its ""Morning Meeting"" every weekday at 10:20 a.m. ET.",0.107124,Neutral,166.3,166.28,166.43,164.08,7342708.0,78675.0,165.711369
2022-09-20,CIOs say data management is critical for successful AI adoption in new global research report by MIT Technology Review Insights,https://www.prnewswire.com/news-releases/cios-say-data-management-is-critical-for-successful-ai-adoption-in-new-global-research-report-by-mit-technology-review-insights-301627279.html,"CAMBRIDGE, Mass., Sept. 20, 2022 /PRNewswire/ -- A new survey report by MIT Technology Review Insights highlights AI and data management as essential pillars to enterprise success, but found that the majority of survey respondents cited data mismanagement as a critical factor that could ...",0.169953,Somewhat-Bullish,165.22,164.97,165.9,164.32,7080203.0,85277.0,164.944158
2022-09-21,"WaveDancer, PayPal, Mars, Johnson & Johnson and + 250 Speakers to Share their Knowledge at Blockchain Expo North America",https://www.globenewswire.com/news-release/2022/09/21/2520487/0/en/WaveDancer-PayPal-Mars-Johnson-Johnson-and-250-Speakers-to-Share-their-Knowledge-at-Blockchain-Expo-North-America.html,"FAIRFAX, Va., Sept. 21, 2022 ( GLOBE NEWSWIRE ) -- WaveDancer, Inc. ( NASDAQ: WAVD ) announced today that they will be joining hundreds of blockchain specialists in Santa Clara, California on the October 5th and 6 th to share their insights about the most recent developments within the ...",0.261016,Somewhat-Bullish,165.02,163.28,166.795,163.24,7994742.0,97529.0,165.043206
2022-09-22,"October: Largest Industrial Metaverse, Enterprise AR/VR/MR  ( XR )  Event Comes to San Diego; Hear Enterprises, Discover Immersive Solutions for Business & Industry",https://www.prnewswire.com/news-releases/october-largest-industrial-metaverse-enterprise-arvrmr-xr-event-comes-to-san-diego-hear-enterprises-discover-immersive-solutions-for-business--industry-301629010.html,"October: Largest Industrial Metaverse, Enterprise AR/VR/MR ( XR ) Event Comes to San Diego. Hear Enterprises, Discover Immersive Solutions for Business & Industry PR ...",0.357038,Bullish,163.15,166.18,167.16,162.83,7360960.0,97100.0,166.109387
2022-09-23,"US Stock Market: How the market moved up from Covid-lows before the big crash, in 3 graphs | The Financial Express",https://www.financialexpress.com/investing-abroad/featured-stories/us-stock-market-how-the-market-moved-up-from-covid-lows-before-the-big-crash-in-3-graphs/2688948/,"US Stock Market: How the market moved up from Covid-lows before the big crash, in 3 graphs The Financial Express ...",0.033349,Neutral,165.74,166.72,167.48,164.66,9539928.0,116545.0,166.451741
2022-09-26,Baltimore Business Wins State-Wide Ethics Award,https://www.prnewswire.com/news-releases/baltimore-business-wins-state-wide-ethics-award-301633376.html,"Next Day Animations Announced Winner in BBB of Greater Maryland Torch Awards BALTIMORE, Sept. 26, 2022 /PRNewswire/ -- The Better Business Bureau of Greater Maryland recently announced Next Day Animations as a winner of the 2022 Torch Awards for Ethics.",0.566581,Bullish,165.8,165.7,166.84,164.38,8674235.0,103340.0,165.697243
2022-09-27,BMY: 1 Stock Living up to Its Name This Year,https://stocknews.com/news/bmy-jnj-mrk-nvs-1-stock-living-up-to-its-name-this-year/,"Bristol-Myers Squibb Company ( BMY ) discovers, develops, licenses, manufactures, and markets biopharmaceutical products globally. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and Covid-19 diseases.",0.216356,Somewhat-Bullish,166.36,164.94,167.67,164.4,8609309.0,106639.0,165.404182
2022-09-28,"Covid vaccination linked to slight increase in menstrual cycle, NIH study confirms",https://www.cnbc.com/2022/09/28/covid-vaccination-linked-to-slight-increase-in-the-length-of-menstrual-cycle-nih-study-finds.html,"A change in menstrual cycle length of eight days or less is considered within the normal range of variation, according to NIH.",0.016433,Neutral,166.245,166.36,167.38,165.1,8586642.0,98820.0,166.38702
2022-09-29,Is Johnson & Johnson a Buy?,https://www.fool.com/investing/2022/09/29/is-johnson-johnson-a-buy/,"The healthcare giant has been a fairly stable investment this year, but does it belong in your portfolio for the long term?",0.277408,Somewhat-Bullish,166.48,164.53,167.17,163.89,6962908.0,88143.0,164.633851
2022-09-30,MSFT: 3 Stocks to Add to Your Portfolio Before It's Too Late,https://stocknews.com/news/msft-hca-apa-3-stocks-to-add-to-your-portfolio-before-its-too/,"This month, the Fed's third consecutive 75-basis-point rate hike has led to a broad-based stock market sell-off, sending the S&P 500 to a new low for the year.",0.265943,Somewhat-Bullish,165.0,163.36,165.74,163.32,8936896.0,86979.0,164.068054
2022-10-03,What Does A Recession Mean For Me? And What Are The Best Places To Invest Money Right Now?,https://www.forbes.com/sites/qai/2022/10/03/what-does-a-recession-mean-for-me-and-what-are-the-best-places-to-invest-money-right-now/,"It's difficult to prepare your investment portfolio for a recession, but keeping an eye on the long term is a good place to start.",-0.088311,Neutral,164.29,163.2,164.38,161.7,8625891.0,95877.0,163.288328
2022-10-04,"DEA-Licensed Pharmaceutical Cannabis Research Company Announces $20M Series A Funding Round - Johnson & Johnson  ( NYSE:JNJ ) , GSK  ( NYSE:GSK ) ",https://www.benzinga.com/markets/cannabis/22/10/29141376/dea-licensed-pharmaceutical-cannabis-research-company-announces-20m-series-a-funding-round,"The Biopharmaceutical Research Company ( BRC ) , an active DEA pharmaceutical cannabis license holder, announced the completion of a $20 million Series A fundraise, that will enable the company to scale its operations and increase its product offering, conduct sponsored research, and execute on ...",0.314662,Somewhat-Bullish,163.85,165.62,166.0,162.92,6196323.0,85434.0,165.219995
2022-10-05,U.S. judge temporarily blocks two state lawsuits over J&J talc marketing,https://www.reuters.com/markets/us/us-judge-temporarily-blocks-two-state-lawsuits-over-jj-talc-marketing-2022-10-05/,"Oct 5 ( Reuters ) - A U.S. bankruptcy judge has blocked New Mexico and Mississippi from pursuing lawsuits accusing Johnson & Johnson ( JNJ.N ) of misleading consumers about the safety of its talc products, such as its baby powder, for now. U.S.",-0.228027,Somewhat-Bearish,165.02,165.11,166.04,164.21,4520244.0,59060.0,165.157069
2022-10-06,"2 Smart Stocks to Invest $1,000 In Right Now",https://www.fool.com/investing/2022/10/06/2-smart-stocks-to-invest-1000-in-right-now/,"These stocks are trading down, but it would be a mistake to overlook them in the current market.",0.207327,Somewhat-Bullish,164.79,161.91,165.0,161.69,5819403.0,79022.0,162.602014
2022-10-07,"Too Hot: Jobs Growth Near Estimates, But Still Too Strong for the Market's Liking - Advanced Micro Devices  ( NASDAQ:AMD ) , Canopy Gwth  ( NASDAQ:CGC ) ",https://www.benzinga.com/markets/penny-stocks/22/10/29186996/too-hot-jobs-growth-near-estimates-but-still-too-strong-for-the-markets-liking,"Jobs growth in September was right down the middle of the fairway at 263,000, according to the Department of Labor. Unfortunately for any bulls out there, the market appeared to be hoping for a slice. Major stock indexes retreated as investors gleaned the numbers.",-0.036154,Neutral,161.77,160.2,162.22,159.17,6329139.0,83812.0,160.415886
2022-10-10,Delhi HC directs L'Oreal to pay profiteered amount of Rs 186 crore,https://www.business-standard.com/article/companies/delhi-hc-directs-l-oreal-to-pay-profiteered-amount-of-rs-186-crore-122101000929_1.html,"The court, which clubbed the petitions, had posted the matter for next hearing on October ...",0.088493,Neutral,160.63,160.41,161.28,159.18,5281192.0,66555.0,160.29484
2022-10-11,"3 takeaways from our daily meeting: Defensive stocks, trimming semis, Meta downgrade",https://www.cnbc.com/2022/10/11/takeaways-from-our-meeting-defensives-trimming-semis-meta-downgrade.html,"The Investing Club holds its ""Morning Meeting"" every weekday at 10:20 a.m. ET.",0.045781,Neutral,160.37,162.73,164.11,160.37,6154855.0,76241.0,162.744965
2022-10-12,"3 takeaways from our daily meeting: Wall Street's bounce, small buy, reviewing analyst notes",https://www.cnbc.com/2022/10/12/3-takeaways-from-our-daily-meeting-wall-streets-bounce-buying-el-reviewing-analyst-notes.html,"The Investing Club holds its ""Morning Meeting"" every weekday at 10:20 a.m. ET.",0.270131,Somewhat-Bullish,162.94,162.69,164.88,162.495,4312478.0,61999.0,163.356786
2022-10-13,Microsoft  ( MSFT )  to Launch an App to Make Hybrid Work Easier,https://www.zacks.com/stock/news/1991689/microsoft-msft-to-launch-an-app-to-make-hybrid-work-easier,Microsoft (MSFT) to launch an app that helps the hybrid workforce decide when to go to the office.,0.24937,Somewhat-Bullish,160.89,165.15,165.99,160.7481,6351146.0,80536.0,164.369756
2022-10-14,Why Johnson & Johnson  ( JNJ )  is Poised to Beat Earnings Estimates Again,https://www.zacks.com/stock/news/1992259/why-johnson-johnson-jnj-is-poised-to-beat-earnings-estimates-again,Johnson & Johnson (JNJ) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.,0.363156,Bullish,164.44,164.46,165.68,163.6,5635569.0,71394.0,164.654155
2022-10-17,"Solid Start: Week Begins in the Green After Bank of America Earnings Impress, Yields Fall - Bank of America  ( NYSE:BAC ) ",https://www.benzinga.com/news/earnings/22/10/29291358/solid-start-week-begins-in-the-green-after-bank-of-america-earnings-impress-yields-fall,"( Monday Market Open ) Falling Treasury yields, hopes for improved stability in the U.K., and early strength in mega-cap stocks gave the market an initial boost Monday. But don't get too comfortable. Everyone's seen the wild swings lately, and volatility remains high with lots of major earnings ...",-0.024326,Neutral,165.4,166.59,167.21,165.01,6666435.0,87118.0,166.507195
2022-10-18,"J&J  ( JNJ )  Beats on Q3 Earnings, Cuts 2022 Sales View on Fx Woes",https://www.zacks.com/stock/news/1993589/jj-jnj-beats-on-q3-earnings-cuts-2022-sales-view-on-fx-woes,J&J (JNJ) beats estimates for third-quarter earnings as well as sales. It lowers the full-year sales guidance. Stock up ...,0.083834,Neutral,165.0,166.01,167.17,163.05,10864677.0,126493.0,165.856755
2022-10-19,JNJ Beats on Q3 Earnings: ETFs in Focus,https://www.zacks.com/stock/news/1994320/jnj-beats-on-q3-earnings-etfs-in-focus,Johnson & Johnson (JNJ) continued with its long streak of earnings beat. It outpaced revenue estimates and raised its full-year revenue guidance.,0.284824,Somewhat-Bullish,166.0,164.69,166.25,163.89,10021281.0,93780.0,164.658448
2022-10-20,"Consumer Purchase Intent More than Doubles When Socially Conscious Brands Engage Advertising Media Partners that Share Common Values, According to UM's Future Impact Study",https://www.prnewswire.com/news-releases/consumer-purchase-intent-more-than-doubles-when-socially-conscious-brands-engage-advertising-media-partners-that-share-common-values-according-to-ums-future-impact-study-301655132.html,"New Research Reveals Causal Effect Between Brand Social Values and Increased Business Performance NEW YORK, Oct. 20, 2022 /PRNewswire/ -- UM, the global media agency network of IPG Mediabrands, today released its groundbreaking ""Future Impact"" study at Advertising Week New York.",0.568562,Bullish,165.0,165.11,165.74,164.33,5632210.0,76711.0,164.964494
2022-10-21,This Is What Whales Are Betting On Johnson & Johnson - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/markets/options/22/10/29361927/this-is-what-whales-are-betting-on-johnson-johnson,"A whale with a lot of money to spend has taken a noticeably bullish stance on Johnson & Johnson. Looking at options history for Johnson & Johnson JNJ we detected 12 strange trades. If we consider the specifics of each trade, it is accurate to state that 50% of the investors opened trades with ...",0.168422,Somewhat-Bullish,164.71,168.71,169.37,164.43,8452392.0,80499.0,167.726083
2022-10-24,"2 takeaways from our daily meeting: We like health care and staples, Club names in the news",https://www.cnbc.com/2022/10/24/2-takeaways-from-our-daily-meeting-we-like-health-care-and-staples-club-names-in-the-news.html,"The Investing Club holds its ""Morning Meeting"" every weekday at 10:20 a.m. ET.",0.200494,Somewhat-Bullish,169.81,170.98,172.08,169.25,6832900.0,85580.0,171.135559
2022-10-25,A $4 Billion Ohio RIA Who 'Looks Through The Noise' And Loves Dividends,https://www.forbes.com/sites/sergeiklebnikov/2022/10/25/a-4-billion-ohio-ria-who-looks-through-the-noise-and-loves-dividends/,Findley was fascinated by the stock market from an early age and always knew he wanted to work in the business.,0.35281,Bullish,170.17,170.71,171.11,168.52,5652671.0,75779.0,170.496459
2022-10-26,Looking Into Johnson & Johnson's Recent Short Interest - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/short-sellers/22/10/29421605/looking-into-johnson-johnsons-recent-short-interest,"Johnson & Johnson's JNJ short percent of float has fallen 12.24% since its last report. The company recently reported that it has 11.23 million shares sold short, which is 0.43% of all regular shares that are available for trading.",0.237013,Somewhat-Bullish,171.32,172.21,172.57,170.52,6095706.0,83074.0,172.122431
2022-10-27,"Top Analyst Reports for UnitedHealth, Johnson & Johnson, & Walmart",https://www.zacks.com/research-daily/1998671/top-analyst-reports-for-unitedhealth-johnson-johnson-walmart,"Today's Research Daily features new research reports on 16 major stocks, including UnitedHealth Group Incorporated (UNH), Johnson & Johnson (JNJ) and Walmart Inc. (WMT).",0.263253,Somewhat-Bullish,172.35,172.31,173.43,171.72,5369017.0,74570.0,172.64691
2022-10-28,"AbbVie  ( ABBV )  Beats on Q3 Earnings, Lags Sales, Narrows '22 View",https://www.zacks.com/stock/news/2010713/abbvie-abbv-beats-on-q3-earnings-lags-sales-narrows-22-view,"AbbVie's earnings (ABBV) beat estimates for third-quarter 2022, while sales miss the same. Shares drop in pre-market trading after it narrows down its full-year earnings guidance.",0.111059,Neutral,173.0,174.87,175.39,172.594,6052533.0,79026.0,174.478723
2022-10-31,Why Sonnet BioTherapeutics  ( SONN )  Stock Is Skyrocketing Today - Sonnet BioTherapeutics  ( NASDAQ:SONN ) ,https://www.benzinga.com/general/biotech/22/10/29479633/sonnet-biotherapeutics-shares-jump-after-janssen-pact-for-its-three-product-candidates,"Sonnet BioTherapeutics Holdings Inc SONN announced a collaboration agreement with Janssen Biotech Inc, a Johnson & Johnson JNJ unit. In vitro and in vivo efficacy of SON-1010 ( IL12-FHAB ) , SON-1210 ( IL12-FHAB-IL15 ) , and SON-1410 ( IL18-FHAB-IL12 ) will be evaluated in combination with ...",0.386842,Bullish,174.52,173.97,175.16,173.42,7795023.0,81019.0,173.974151
2022-11-01,"Dow Drops Over 200 Points; Crude Oil Rises Sharply - Adams Resources & Energy  ( AMEX:AE ) , Abiomed  ( NASDAQ:ABMD ) ",https://www.benzinga.com/news/earnings/22/11/29505635/dow-drops-over-200-points-crude-oil-rises-sharply,"U.S. stocks traded lower midway through trading, with the Dow Jones dropping more than 200 points on Tuesday. The Dow traded down 0.66% to 32,517.70 while the NASDAQ fell 0.86% to 10,894.04. The S&P 500 also fell, dropping, 0.65% to 3,846.62.",0.152911,Somewhat-Bullish,174.06,173.09,174.63,170.42,6977168.0,99494.0,172.803199
2022-11-02,Asia stocks fall after Fed says more US rate hikes likely,https://apnews.com/article/inflation-china-asia-business-financial-markets-c2b9c1d36006dc3b8815aa18f0fe8ac1,Stocks move lower on Wall Street ahead of Fed news on rates The Associated Press ...,-0.211876,Somewhat-Bearish,172.89,170.43,173.94,170.29,6769496.0,90781.0,171.397028
2022-11-03,What big tech and Blackstone have in common with GE,https://www.economist.com/business/2022/11/03/what-big-tech-and-blackstone-have-in-common-with-ge,"Unaccountable bosses, declining returns on capital and fed-up investors ...",0.120983,Neutral,169.81,170.72,171.47,168.94,4814890.0,75301.0,170.455489
2022-11-04,Market Rally Tumbles On Hawkish Powell: Weekly Review,https://www.investors.com/news/stock-market-rally-tumbles-on-hawkish-fed-chief-powell-jobs-earnings-also-in-focus-weekly-review/,"The stock market rally came under pressure as the major indexes reversed sharply lower following the latest big Fed rate hike and Fed chief Jerome Powell's hawkish comments about peak rates. The jobs report was mixed, with nonfarm payrolls higher than expected but unemployment also climbing.",-0.056336,Neutral,171.56,171.48,172.5,169.24,5284716.0,75304.0,170.847544
2022-11-07,Summer internships shine for students of top B-schools as stipends surge,https://www.business-standard.com/article/education/summer-placements-stipends-at-top-b-schools-see-double-digit-growth-122110701560_1.html,IIM Kozhikode posted the highest stipend of Rs 6.47 lakhs while mean stipend saw a 25 per cent increase over last year to Rs 2.5 lakhs this year at the conclusion of its summer internship ...,0.246695,Somewhat-Bullish,171.67,172.98,173.85,171.44,6613628.0,72695.0,172.821916
2022-11-08,2 Healthcare Stocks You Can Buy and Hold for the Next Decade,https://www.fool.com/investing/2022/11/08/2-healthcare-stocks-you-can-buy-and-hold-for-the-n/,These robust businesses will be around well beyond the next 10 years.,0.249277,Somewhat-Bullish,173.13,173.84,174.6908,172.18,5121794.0,76443.0,173.824646
2022-11-09,Genmab Announces Financial Results for the First Nine Months of 2022,https://www.globenewswire.com/news-release/2022/11/09/2552274/0/en/Genmab-Announces-Financial-Results-for-the-First-Nine-Months-of-2022.html,"November 9, 2022 Copenhagen, Denmark. Interim Report for the First Nine Months Ended September ...",0.17483,Somewhat-Bullish,174.27,172.45,175.0,172.34,6122119.0,81678.0,173.534155
2022-11-10,The Corporate Proxy Ballot Takes Center Stage For ESG,https://www.forbes.com/sites/chris-perry/2022/11/10/the-corporate-proxy-ballot-takes-center-stage-for-esg/,"By 2025, it is expected that around 33% of all global assets under management will have ESG mandates.",0.23667,Somewhat-Bullish,174.35,174.47,174.77,172.04,7850402.0,92235.0,173.920936
2022-11-11,Bavarian Nordic to Present at Jefferies 2022 London Healthcare Conference,https://www.globenewswire.com/news-release/2022/11/11/2554344/0/en/Bavarian-Nordic-to-Present-at-Jefferies-2022-London-Healthcare-Conference.html,"COPENHAGEN, Denmark - November 11, 2022 - Bavarian Nordic A/S ( OMX: BAVA ) today announced that Paul Chaplin, President & CEO will provide a corporate presentation at the Jefferies 2022 London Healthcare Conference on Thursday, November 17, 2022 at 8:35 am GMT ( 9:35 am CET ) .",0.238244,Somewhat-Bullish,172.73,169.25,173.11,166.82,11045529.0,165212.0,168.946862
2022-11-14,"The Intravascular Catheters Market Is Set To Reach $9 Billion By 2026, Driven By Rising Hospitalization Rate As Per The Business Research Company's Intravascular Catheters Global Market Report 2022",https://www.benzinga.com/pressreleases/22/11/g29705767/the-intravascular-catheters-market-is-set-to-reach-9-billion-by-2026-driven-by-rising-hospitalizat,"LONDON, Nov. 14, 2022 ( GLOBE NEWSWIRE ) -- Avail a limited period discount of 33% on our uniquely designed Opportunities and Strategies market research reports. Contact us today and make winning strategies!",0.104246,Neutral,170.25,171.91,173.26,170.25,6568234.0,90785.0,172.160936
2022-11-15,Investors Heavily Search Johnson & Johnson  ( JNJ ) : Here is What You Need to Know,https://www.zacks.com/stock/news/2018347/investors-heavily-search-johnson-johnson-jnj-here-is-what-you-need-to-know,"Zacks.com users have recently been watching Johnson & Johnson (JNJ) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.",0.217438,Somewhat-Bullish,172.19,172.39,173.0,170.521,9296836.0,86317.0,172.086023
2022-11-16,"Breast Implant Market Size is projected to reach USD 4.68 Billion by 2031, growing at a CAGR of 7.8%: Straits Research",https://www.benzinga.com/pressreleases/22/11/g29752040/breast-implant-market-size-is-projected-to-reach-usd-4-68-billion-by-2031-growing-at-a-cagr-of-7-8,"New York, United States, Nov. 16, 2022 ( GLOBE NEWSWIRE ) -- Breast implants are medical devices used to increase breast size ( augmentation ) or to restore breast tissue after a mastectomy ( reconstruction ) . Breast implants are inserted under the breast tissue or the chest muscle.",0.072264,Neutral,173.64,173.46,174.99,173.13,5466374.0,71385.0,173.842091
2022-11-17,Johnson & Johnson  ( JNJ )  Up 5.3% Since Last Earnings Report: Can It Continue?,https://www.zacks.com/stock/news/2019529/johnson-johnson-jnj-up-53-since-last-earnings-report-can-it-continue,Johnson & Johnson (JNJ) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.,0.081967,Neutral,173.0,174.86,174.99,172.98,4439718.0,66515.0,174.262699
2022-11-18,CERENOVUS Reveals Positive Outcomes with Thrombectomy in Global Registry Studying Stroke-Inducing Blood Clots,https://www.prnewswire.com/news-releases/cerenovus-reveals-positive-outcomes-with-thrombectomy-in-global-registry-studying-stroke-inducing-blood-clots-301682819.html,EXCELLENT study demonstrates real-world benefits of CERENOVUS' EMBOTRAP™ Revascularization Devices on clinical outcomes and first pass reperfusion,0.236841,Somewhat-Bullish,175.0,176.2,176.64,174.623,6524836.0,72512.0,175.770778
2022-11-21,This Is What Whales Are Betting On Johnson & Johnson - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/markets/options/22/11/29807583/this-is-what-whales-are-betting-on-johnson-johnson,"Someone with a lot of money to spend has taken a bearish stance on Johnson & Johnson JNJ. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",0.173979,Somewhat-Bullish,175.89,175.97,176.55,174.83,5693259.0,76674.0,175.856529
2022-11-22,Recession-Proof Industries To Pump Up Your Portfolio,https://www.forbes.com/sites/qai/2022/11/22/recession-proof-industries-to-pump-up-your-portfolio/,"As inflation continues - and the Federal Reserve hikes interest rates to fight it - a recession appears increasingly likely. And these industries are the least likely to be affected if a recession does, indeed, materialize.",0.044139,Neutral,176.4,176.82,177.19,176.33,4699620.0,66611.0,176.799086
2022-11-23,2 Safe Dividend Stocks to Buy Hand Over Fist,https://www.fool.com/investing/2022/11/23/2-safe-dividend-stocks-to-buy-hand-over-fist/,"These businesses may not be ""exciting,"" but that's not such a bad thing right now.",0.217674,Somewhat-Bullish,176.44,177.01,177.4,176.01,5371349.0,67098.0,176.683702
2022-11-25,LMT: 4 Stocks You'll Regret Not Buying on the Dip,https://stocknews.com/news/lmt-elv-hca-aci-4-stocks-youll-regret-not-buying-on-the-dip/,"CNBC's Jim Cramer believes the market's current rally could last through the middle of next month. The October producer price index data signaled that inflation is cooling. Moreover, the minutes from the Fed's policy meeting earlier this month suggest that the central bank will slow down the ...",0.326911,Somewhat-Bullish,177.38,177.24,178.12,176.86,3058061.0,31978.0,177.220293
2022-11-28,Johnson & Johnson  ( JNJ )  Is a Trending Stock: Facts to Know Before Betting on It,https://www.zacks.com/stock/news/2022784/johnson-johnson-jnj-is-a-trending-stock-facts-to-know-before-betting-on-it,"Zacks.com users have recently been watching Johnson & Johnson (JNJ) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.",0.210914,Somewhat-Bullish,176.75,177.33,177.77,176.56,6168677.0,71392.0,177.171769
2022-11-29,"Not Out of the Woods: Investors Await Fresh Data and Fed Comments - Apple  ( NASDAQ:AAPL ) , Caterpillar  ( NYSE:CAT ) ",https://www.benzinga.com/markets/22/11/29892733/not-out-of-the-woods-investors-await-fresh-data-and-fed-comments,"( Tuesday Market Open ) The ""risk-on"" pattern that dominated Wall Street ahead of Thanksgiving faces fresh challenges this week from China, the Fed, and a host of economic data.",-0.043425,Neutral,177.01,176.09,177.26,174.66,6698157.0,79089.0,175.846923
2022-11-30,Why Horizon Therapeutics Stock Is Skyrocketing Today,https://www.fool.com/investing/2022/11/30/why-horizon-therapeutics-stock-is-skyrocketing-tod/,Three big drugmakers could be interested in acquiring Horizon.,0.014304,Neutral,176.37,178.0,178.01,174.78,13230718.0,89453.0,177.279101
2022-12-01,"Anti-Retroviral Drugs Market is expected to generate a revenue of USD 45.50 Billion by 2030, Globally, at 6.70% CAGR: Verified Market Research®",https://www.benzinga.com/pressreleases/22/12/g29923924/anti-retroviral-drugs-market-is-expected-to-generate-a-revenue-of-usd-45-50-billion-by-2030-global,"Jersey City, New Jersey, Dec. 01, 2022 ( GLOBE NEWSWIRE ) -- Verified Market Research recently published a report, ""Anti-Retroviral Drugs Market"" By Type ( Protease Inhibitors, Non-Nucleoside Reverse Transcriptase Inhibitors ) , By Application ( HIV/AIDS, Herpes, Influenza ) , and By Geography.",0.121507,Neutral,179.0,178.74,179.96,177.77,6272509.0,79698.0,178.604009
2022-12-02,"Market Rally At Key Level On Powell, Jobs Report: Weekly Review",https://www.investors.com/news/stock-market-rally-fights-at-key-level-on-powell-inflation-data-jobs-report/,"The stock market rally powered higher for much of the week with the S&P 500 moving above its 200-day moving average. Fed chief Jerome Powell reinforced expectations for slower rate hikes, while a key inflation report showed prices pressures moderating.",-0.024657,Neutral,177.5,178.88,178.96,176.96,5813137.0,77799.0,178.086711
2022-12-05,"If You Bought 100 Shares of Johnson & Johnson 10 Years Ago, This Is How Much You Would Have Today",https://www.fool.com/investing/2022/12/05/if-bought-shares-johnson-johnson-how-much-today/,The stock for this healthcare stalwart beat the S&P 500's performance over the past decade.,0.134747,Neutral,178.36,178.78,179.36,178.0,5116596.0,72835.0,178.747206
2022-12-06,Adoption of Robot-Assisted Surgery Is A Major Trend In The Medical Aesthetics Market As Per The Business Research Company's Medical Aesthetics Global Market Report 2022,https://www.benzinga.com/pressreleases/22/12/g29978426/adoption-of-robot-assisted-surgery-is-a-major-trend-in-the-medical-aesthetics-market-as-per-the-bu,"LONDON, Dec. 06, 2022 ( GLOBE NEWSWIRE ) -- Avail a limited period discount of 33% on our uniquely designed Opportunities and Strategies market research reports. Contact us today and make winning strategies!",0.157823,Somewhat-Bullish,179.92,176.1,180.0,175.93,7938620.0,82735.0,177.054785
2022-12-07,Hair Care Market to Hit USD 112.97 Billion by 2028 | Industry to Generate 5.6% CAGR during  ( 2021-2028 ) ,https://www.benzinga.com/pressreleases/22/12/g29989629/hair-care-market-to-hit-usd-112-97-billion-by-2028-industry-to-generate-5-6-cagr-during-2021-2028,"Pune, India, Dec. 07, 2022 ( GLOBE NEWSWIRE ) -- According to Fortune Business Insights™, the global hair care market size is expected to showcase exponential growth by reaching USD 112.97 billion by 2028 while exhibiting a CAGR of 5.6% between 2021 and 2028.",0.269499,Somewhat-Bullish,176.57,177.17,177.88,176.23,5690081.0,70936.0,177.056375
2022-12-08,"The Surgical Retractors Market Size Is Set To Reach $2.8 Billion By 2026, With The Rise In Number Of Surgical Procedures As Per The Business Research Company's Surgical Retractors Global Market Report 2022",https://www.benzinga.com/pressreleases/22/12/g30010347/the-surgical-retractors-market-size-is-set-to-reach-2-8-billion-by-2026-with-the-rise-in-number-of,"LONDON, Dec. 08, 2022 ( GLOBE NEWSWIRE ) -- According to The Business Research Company's research on the surgical retractors market, an increasing number of surgical procedures is expected to propel the growth of the surgical retractors market going forward.",0.161053,Somewhat-Bullish,176.82,177.2,177.47,176.34,4795301.0,62898.0,177.028503
2022-12-09,Press release Biocartis Group NV: Disclosure of transparency notifications,https://www.globenewswire.com/news-release/2022/12/09/2571222/0/en/Press-release-Biocartis-Group-NV-Disclosure-of-transparency-notifications.html,PRESS RELEASE: REGULATED INFORMATION 9 December ...,0.123174,Neutral,177.12,175.74,177.89,175.66,4557924.0,59202.0,176.294529
2022-12-12,Why Horizon Therapeutics Stock Is Soaring Today,https://www.fool.com/investing/2022/12/12/why-horizon-therapeutics-stock-is-soaring-today/,Amgen's planned acquisition of Horizon could close in the first half of next year.,0.328553,Somewhat-Bullish,175.95,177.84,177.87,175.6,4877988.0,61786.0,177.051564
2022-12-13,Endoscopy Equipment Market Worth $59.8 Billion by 2029 - Exclusive Report by Meticulous Research®,https://www.benzinga.com/pressreleases/22/12/g30061016/endoscopy-equipment-market-worth-59-8-billion-by-2029-exclusive-report-by-meticulous-research,"Redding, California, Dec. 13, 2022 ( GLOBE NEWSWIRE ) -- According to a new market research report titled, ""Endoscopy Equipment Market by Type ( Endoscope [Flexible, Rigid, Capsule], Visualization System, Accessories [Insufflators, Mouthpieces], Software ) , Application ( Colonoscopy, ...",0.115606,Neutral,179.1,179.21,180.2,178.3083,9117505.0,101286.0,179.411704
2022-12-14,"The Topical Drug Delivery Market Is Expected To Grow At An 8% Rate, Driven By The Rise In Diabetes Cases As Per The Business Research Company's Topical Drug Delivery Global Market Report 2022",https://www.benzinga.com/pressreleases/22/12/g30078754/the-topical-drug-delivery-market-is-expected-to-grow-at-an-8-rate-driven-by-the-rise-in-diabetes-c,"LONDON, Dec. 14, 2022 ( GLOBE NEWSWIRE ) -- According to The Business Research Company's research on the topical drug delivery market, the growing prevalence of diabetes is expected to propel the growth of the topical drug delivery market going forward.",0.177062,Somewhat-Bullish,178.58,179.76,181.039,178.58,9397790.0,93229.0,180.06397
2022-12-15,"As Per The Clinical Chemistry Market Forecast, The Rising Prevalence Of Chronic Diseases Will Drive The Market As Per The Business Research Company's Clinical Chemistry Global Market Report 2022",https://www.benzinga.com/pressreleases/22/12/g30095744/as-per-the-clinical-chemistry-market-forecast-the-rising-prevalence-of-chronic-diseases-will-drive,"LONDON, Dec. 15, 2022 ( GLOBE NEWSWIRE ) -- According to The Business Research Company's research on the clinical chemistry market, the increasing prevalence of chronic diseases is expected to propel the growth of the clinical chemistry market going forward.",0.16752,Somewhat-Bullish,179.2,177.49,179.84,176.4,7585665.0,82135.0,177.400526
2022-12-16,"Pharmaceutical Marketing Market Research Report by Type, Business Model, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19",https://www.prnewswire.com/news-releases/pharmaceutical-marketing-market-research-report-by-type-business-model-region---global-forecast-to-2027---cumulative-impact-of-covid-19-301704473.html,Pharmaceutical Marketing Market Research Report by Type ... PR ...,0.255975,Somewhat-Bullish,177.0,175.67,177.0,174.86,18807938.0,87937.0,175.817111
2022-12-19,Talent Development Platform GrowthSpace Awarded Across the Board in G2 Winter Report,https://www.prnewswire.com/il/news-releases/talent-development-platform-growthspace-awarded-across-the-board-in-g2-winter-report-301706349.html,Talent Development Platform GrowthSpace Awarded Across the ... PR ...,0.562194,Bullish,175.35,175.48,176.165,174.07,5733732.0,61764.0,175.313892
2022-12-20,20 High-Yield Dividend Stocks to Consider for 2022,https://www.fool.com/investing/stock-market/types-of-stocks/dividend-stocks/high-yield-dividend-stocks/,A list of high-yielding dividend stocks to consider buying now.,0.414702,Bullish,176.0,175.67,176.44,175.17,6172909.0,67839.0,175.7985
2022-12-21,Orthopedic Implants Market is expected to grow from USD 41.30 billion in 2021 to USD 69.38 billion by 2029 : GreyViews,https://www.benzinga.com/pressreleases/22/12/g30162522/orthopedic-implants-market-is-expected-to-grow-from-usd-41-30-billion-in-2021-to-usd-69-38-billion,"Pune India, Dec. 21, 2022 ( GLOBE NEWSWIRE ) -- The market has been studied for the below mentioned-segmentation and regional analysis for North America, Europe, Asia, South America, and Middle East and Africa.",0.113878,Neutral,176.27,177.68,178.18,175.65,5467733.0,67340.0,177.278891
2022-12-22,What the end of the stock market's 'FANG-era' means for ETFs,https://www.marketwatch.com/story/what-the-end-of-the-stock-markets-fang-era-means-for-etfs-11671730188,"The S&P 500's 'FANG-era' is ending, with the waning influence of Big Tech stocks rippling through the exchange-traded fund industry, according to Strategas.",0.11922,Neutral,176.77,177.03,177.51,175.34,5703155.0,64072.0,176.771692
2022-12-23,Gilead  ( GILD )  Gets FDA Nod for Twice-Yearly HIV Treatment,https://www.zacks.com/stock/news/2032044/gilead-gild-gets-fda-nod-for-twice-yearly-hiv-treatment,Gilead'ls (GILD) HIV franchise gets a boost with FDA's approval of twice-yearly HIV treatment Sunlenca for the treatment of HIV-1 infection in heavily treatment-experienced adults with multi-drug resistance.,0.132754,Neutral,176.67,177.48,177.52,175.81,3681652.0,50486.0,177.082671
2022-12-27,JPST: 3 ETFs to Consider Buying Before January,https://stocknews.com/news/jpst-pph-pbj-3-etfs-to-consider-buying-before-january/,"The Federal Reserve's aggressive rate hikes this year are finally yielding results, as inflation eased for the second consecutive month in November. The consumer price index in November rose 7.1% year-over-year and 0.1% sequentially, coming below analyst estimates.",0.113631,Neutral,178.11,177.43,178.35,176.99,3061043.0,43418.0,177.587412
2022-12-28,Contact Lens Market will worth is USD 21.6 billion by 2029 & it will grow at a CAGR of 4.5% till 2029 : GreyViews,https://www.benzinga.com/pressreleases/22/12/g30217010/contact-lens-market-will-worth-is-usd-21-6-billion-by-2029-it-will-grow-at-a-cagr-of-4-5-till-2029,"Pune India, Dec. 28, 2022 ( GLOBE NEWSWIRE ) -- The market has been studied for the below mentioned-segmentation and regional analysis for North America, Europe, Asia, South America, and Middle East and Africa.",0.257588,Somewhat-Bullish,177.76,176.66,178.45,176.65,2633210.0,43442.0,177.182421
2022-12-29,Microsoft  ( MSFT )  Excel's New Features to Make Formulas Simpler,https://www.zacks.com/stock/news/2033416/microsoft-msft-excels-new-features-to-make-formulas-simpler,"Microsoft (MSFT) makes Excel's autocomplete even smarter, at least in the web version that comes with Microsoft 365.",0.196204,Somewhat-Bullish,177.55,177.56,178.3,177.07,2821299.0,49264.0,177.741366
2022-12-30,JNJ: 2 Stocks You Can Buy Now and Hold for the Next 20 Years,https://stocknews.com/news/jnj-moh-2-stocks-you-can-buy-now-and-hold-for-the/,"The central bank raised its policy rate by nearly 400 basis points to rein in inflation this year. As a result, borrowing costs have increased significantly, bumping companies' average cost of capital from their lowest levels in 2021.",0.188202,Somewhat-Bullish,177.49,176.65,177.77,175.4,4178049.0,49212.0,176.432956
2023-01-03,PFE: 1 Stock That Would Be an Excellent Addition to Your Portfolio for Years to Come,https://stocknews.com/news/pfe-jnj-nvo-bmy-1-stock-that-would-be-an-excellent-addition-to-your/,PFE: 1 Stock That Would Be an Excellent Addition to Your Portfolio ... ...,0.255499,Somewhat-Bullish,176.16,178.19,178.38,176.01,6301651.0,68546.0,177.665183
2023-01-04,Worried About 2023? Here's a Safer Way to Invest in Stocks This Year,https://www.fool.com/investing/2023/01/04/worried-about-2023-heres-a-safer-way-to-invest/,"By holding a broad range of stocks and spreading out your investment over the year, you can minimize your overall risk.",0.128501,Neutral,178.89,180.13,180.19,178.48,9735767.0,102915.0,179.557681
2023-01-05,Johnson & Johnson sets up mega-IPO for consumer health unit,https://www.axios.com/2023/01/05/johnson-and-johnson-ipo-consumer-health-tylenol-band-aid,"Johnson & Johnson on Wednesday IPO registration papers for its consumer health products business, which is being spun out under the name Kenvue. Why it matters: This could be the largest U.S. IPO since Rivian went public in late 2021, with Renaissance Capital estimating that Kenvue could raise up ...",0.124283,Neutral,179.02,178.8,179.99,178.41,6209353.0,81445.0,179.009967
2023-01-06,"Tesla Falls Again, but This Nasdaq Stock Is Truly Plunging",https://www.fool.com/investing/2023/01/06/tesla-falls-again-but-this-nasdaq-stock-is-truly-p/,The Nasdaq Composite once again is underperforming the rest of the market.,-0.10597,Neutral,180.13,180.25,180.93,179.39,5683059.0,74409.0,180.054615
2023-01-09,Johnson & Johnson Unusual Options Activity - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/markets/options/23/01/30336949/johnson-johnson-unusual-options-activity,"Someone with a lot of money to spend has taken a bullish stance on Johnson & Johnson JNJ. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",0.15441,Somewhat-Bullish,179.3,175.58,179.76,175.175,7925691.0,98648.0,176.712399
2023-01-10,Best Stocks To Buy In 2023? 2 Health Care Stocks To Know,https://stockmarket.com/featured/best-stocks-to-buy-in-2023-2-health-care-stocks-to-know-2023-01-10,"To get the ball rolling, healthcare stocks refer to investments in companies that operate within the healthcare industry. This industry encompasses a wide range of sectors such as pharmaceuticals, medical devices, biotechnology, and healthcare services.",0.214295,Somewhat-Bullish,175.7,175.16,176.14,174.32,5047967.0,70326.0,175.111245
2023-01-11,Hemp Stock News - Global Hemp Group  ( CSE: GHG )  Announces Execution of Binding LOI with Apollon Formularies PLC,https://www.investorideas.com/news/2023/cannabis/01111CSE-GHG.asp,Hemp Stock News - Global Hemp Group ( CSE: GHG ) Announces ... ...,0.197369,Somewhat-Bullish,175.57,174.88,175.72,172.11,6495794.0,86965.0,174.159347
2023-01-12,"Spot On: CPI Report, Eagerly Awaited, Meets Expectations For Easing Prices But Unlikely to Move Market Much - Apple  ( NASDAQ:AAPL ) , Amazon.com  ( NASDAQ:AMZN ) ",https://www.benzinga.com/markets/23/01/30394000/spot-on-cpi-report-eagerly-awaited-meets-expectations-for-easing-prices-but-unlikely-to-move-market,"( Thursday Market Open ) Today's December Consumer Price Index ( CPI ) report was pretty much right down the middle-which means it may not change the Federal Reserve's thinking about rates. Headline CPI fell 0.1% in December from November, while core CPI, which strips out food and energy, ...",0.019381,Neutral,174.26,174.0,174.706,172.8,4269394.0,68626.0,174.046407
2023-01-13,"Big Bank Earnings Supported by Strong Net Interest Income, But Questions Arise on How Long it Can Last - Citigroup  ( NYSE:C ) , Bank of America  ( NYSE:BAC ) ",https://www.benzinga.com/markets/23/01/30412462/big-bank-earnings-supported-by-strong-net-interest-income-but-questions-arise-on-how-long-it-can-las,( Friday Market Open ) Stocks wobbled Friday as investors digested a mixed set of earnings from four of the country's biggest banks.,0.004836,Neutral,173.19,173.43,174.01,172.38,6075022.0,74266.0,173.415991
2023-01-17,Good Stocks To Invest In Right Now? 3 Defensive Stocks To Watch,https://stockmarket.com/featured/good-stocks-to-invest-in-right-now-3-defensive-stocks-to-watch-2023-01-17,"To start off, defensive stocks are a category of stocks that tend to perform well during economic downturns. These are companies that provide essential goods or services that are in high demand. Even when the economy is not doing well. They are often referred to as ""recession-proof"" stocks.",0.164597,Somewhat-Bullish,174.0,172.36,174.58,172.09,6048700.0,78651.0,172.851311
2023-01-18,What To Expect From Johnson & Johnson's Q4?,https://www.forbes.com/sites/greatspeculations/2023/01/18/what-to-expect-from-johnson--johnsons-q4/,"The company will likely see a steady rise in revenue led by continued market share gains for its drugs - Darzalex, Stelara, Erleada, and Tremfya.",0.164133,Somewhat-Bullish,171.65,169.76,172.0,169.71,7048479.0,99546.0,170.144039
2023-01-19,"Climbing the Wall: As Wall Street Considers Fresh Worrisome Economic Data, Stocks Head Lower",https://www.benzinga.com/markets/23/01/30486260/climbing-the-wall-as-wall-street-considers-fresh-worrisome-economic-data-stocks-head-lower,"( Thursday Market Open ) Yesterday's steep sell-off looked like it might be a wake-up call as earnings season accelerated. This morning's trading picked up where Wednesday left off, with stock index futures losing more ground amid bubbling recession concerns.",-0.114995,Neutral,169.03,169.53,171.28,168.71,6940066.0,86295.0,170.104701
2023-01-20,Could Alphabet Cuts Spell a Potentially Tough Year Ahead for Tech?,https://www.benzinga.com/markets/23/01/30504478/could-alphabet-cuts-spell-a-potentially-tough-year-ahead-for-tech,"( Friday Market Open ) The weekend probably can't come soon enough for the info tech world with Friday's latest round of layoffs. This time, it's Alphabet GOOGL announcing 12,000 job cuts. That follows Microsoft MSFT earlier this week and other major mega-cap tech companies slicing their ...",-0.060092,Neutral,170.1,168.74,170.11,167.48,8620553.0,101477.0,168.663074
2023-01-23,Lowey Dannenberg Notifies Fate Therapeutics Inc.  ( NASDAQ: FATE )  Investors of Securities Class Action Lawsuit and Upcoming Lead Plaintiff Deadline,https://www.benzinga.com/pressreleases/23/01/g30526597/lowey-dannenberg-notifies-fate-therapeutics-inc-nasdaq-fate-investors-of-securities-class-action-l,"WHITE PLAINS, N.Y., Jan. 23, 2023 ( GLOBE NEWSWIRE ) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Fate Therapeutics Inc. ( ""Fate"" or the ""Company"" ) for violations of the federal ...",-0.024344,Neutral,169.1,168.31,169.63,167.9474,8436518.0,113613.0,168.608287
2023-01-24,Earnings Data Deluge,https://www.zacks.com/stock/news/2043416/earnings-data-deluge,"The busiest day of Q4 earnings season so far is here, with plenty of big-name companies reporting ahead of the opening bell. Whether pre-market futures are reacting to results or just doing some profit-taking off recent highs is hard to tell - the Dow is -150 points at this hour, the S&P 500 is ...",0.066749,Neutral,175.0,168.31,175.0,166.01,10543270.0,146725.0,167.648978
2023-01-25,Johnson & Johnson  ( JNJ )  is a Top Dividend Stock Right Now: Should You Buy?,https://www.zacks.com/stock/news/2044222/johnson-johnson-jnj-is-a-top-dividend-stock-right-now-should-you-buy,"Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Johnson & Johnson (JNJ) have what it takes? Let's find out.",0.409082,Bullish,167.17,169.51,169.51,167.08,7100160.0,97274.0,168.648108
2023-01-26,ETFs in Focus on JNJ's Mixed Q4 Earnings Results,https://www.zacks.com/stock/news/2044773/etfs-in-focus-on-jnjs-mixed-q4-earnings-results,The world's biggest healthcare products' maker continued with its long streak of earnings beat and missed revenue estimates.,0.178154,Somewhat-Bullish,169.55,168.89,169.91,168.65,6946231.0,90817.0,169.061951
2023-01-27,"Author Post: New Buyers, New Motivations: Foreign Firms Join The US Biotech Buying Frenzy",https://www.forbes.com/sites/forbesbooksauthors/2023/01/27/new-buyers-new-motivations-foreign-firms-join-the-us-biotech-buying-frenzy/,"""The depreciated value of US biotechnology companies has not gone unnoticed by traditional pharmaceutical conglomerates looking to augment their pipelines at attractive prices."" ...",0.222994,Somewhat-Bullish,168.54,168.23,168.866,167.77,6058104.0,76950.0,168.275556
2023-01-30,"$1,000 Invested In 4 Of The 5 Vaccine Developers Back When WHO Declared COVID-19 An Emergency Yielded Returns",https://www.benzinga.com/general/biotech/23/01/30622252/1-000-invested-in-4-of-the-5-vaccine-developers-back-when-who-declared-covid-19-an-emergency-yiel,"The COVID-19 pandemic emerged in 2019 in China and spread to the rest of the globe in early 2020. Since then, the virus has caused more than 6.8 million deaths. The urgency and the severity of COVID-19 forced biopharma companies to expeditiously develop a vaccine to counter the threat. Moderna, ...",-0.138174,Neutral,167.93,162.0,168.54,161.08,23264460.0,266657.0,163.522465
2023-01-31,J&J  ( JNJ )  Down as Court Rejects Bankruptcy Claim in Talc Lawsuits,https://www.zacks.com/stock/news/2047102/jj-jnj-down-as-court-rejects-bankruptcy-claim-in-talc-lawsuits,"A federal appeals court rejects J&J's (JNJ) efforts to shift over 38,000 lawsuits related to its talcum-based baby powder out of trial courts and into bankruptcy court.",-0.070341,Neutral,161.7,163.42,163.43,161.05,11613109.0,143888.0,162.408383
2023-02-01,"Drug/Biotech Stocks Q4 Earnings Due on Feb 2: GILD, MRK & Others",https://www.zacks.com/stock/news/2047789/drugbiotech-stocks-q4-earnings-due-on-feb-2-gild-mrk-others,Let's look at the four biotech/pharma companies slated to release quarterly results on Feb 2.,0.150526,Somewhat-Bullish,162.99,164.92,165.98,162.4,9868743.0,126895.0,164.320963
2023-02-02,"Genscript Bio Gets Booster From Subsidiary's New Cancer Drug - Legend Biotech  ( NASDAQ:LEGN ) , Johnson & Johnson  ( NYSE:JNJ ) ",https://www.benzinga.com/23/02/30691329/genscript-bio-gets-booster-from-subsidiarys-new-cancer-drug,"After years of losses, Legend Biotech's new cancer drug Cavykti offers it a chance to finally start contributing revenue to its parent, Genscript Biotech Some analysts believe Genscript may have become profitable last year, but also worry over its mounting R&D and sales expenses",0.170807,Somewhat-Bullish,163.0,165.54,166.22,162.8224,10106860.0,139984.0,164.720247
2023-02-03,Veterans Suing Over 3M Earplugs Want Bankruptcy Case Tossed,https://www.wsj.com/articles/veterans-suing-over-3m-earplugs-want-bankruptcy-case-tossed-11675443182,Plaintiffs say a ruling on the Johnson & Johnson talc case supports their opposition to 3M's plan for settling claims.,-0.217213,Somewhat-Bearish,166.03,164.61,166.34,163.89,6868540.0,89157.0,164.519581
2023-02-06,AbbVie  ( ABBV )  to Report Q4 Earnings: What's in the Cards?,https://www.zacks.com/stock/news/2050446/abbvie-abbv-to-report-q4-earnings-whats-in-the-cards,AbbVie's (ABBV) Q4 performance will likely reflect strong drug demand from its immunology and neuroscience franchises. Investors will also enquire about ABBV's plans to counter Humira LOE.,0.184519,Somewhat-Bullish,164.55,163.36,164.8525,163.1,7021104.0,87871.0,163.435094
2023-02-07,Catalent  ( CTLT )  Surges on Rumors of Acquisition by Danaher,https://www.zacks.com/stock/news/2051034/catalent-ctlt-surges-on-rumors-of-acquisition-by-danaher,"Catalent (CTLT) shares gain significantly, following a Bloomberg report about a potential acquisition of the CDMO company by Danaher, a life sciences company.",0.251285,Somewhat-Bullish,161.6,163.4,163.88,161.42,7311118.0,92831.0,162.568622
2023-02-08,JNJ: 3 Stocks to Help You Build Wealth in the Market,https://stocknews.com/news/jnj-ko-azn-3-stocks-to-help-you-build-wealth-in-the-market/,"Expansion of the U.S. economy for the fourth quarter of last year and moderating inflationary pressures led the Fed to choose a less aggressive stance. Hence, the central bank hiked rates by 0.25 percentage points. This revived investor optimism.",0.194378,Somewhat-Bullish,163.3,163.61,164.56,162.8995,6054759.0,73219.0,163.71093
2023-02-09,Highview Capital Expands through New Hires and Promotion,https://www.prnewswire.com/news-releases/highview-capital-expands-through-new-hires-and-promotion-301741236.html,"LOS ANGELES, Feb. 9, 2023 /PRNewswire/ -- Highview Capital, LLC ( ""Highview"" ) , a Los Angeles-based middle-market private equity firm, today announced the hire of Jonathan Greenway as a Managing Director as well as the promotion of Dan Picmann to Managing Director.",0.274803,Somewhat-Bullish,163.63,161.4,164.795,161.07,7949666.0,100184.0,162.118958
2023-02-10,Why Johnson & Johnson  ( JNJ )  is a Top Dividend Stock for Your Portfolio,https://www.zacks.com/stock/news/2052986/why-johnson-johnson-jnj-is-a-top-dividend-stock-for-your-portfolio,"Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Johnson & Johnson (JNJ) have what it takes? Let's find out.",0.39289,Bullish,161.77,162.15,162.79,161.35,7028039.0,78913.0,162.193018
2023-02-13,What Stocks To Buy Today? 2 Defensive Stocks To Know,https://stockmarket.com/featured/what-stocks-to-buy-today-2-defensive-stocks-to-know-2023-02-13,The defensive sector is a group of industries and companies that are known to be less sensitive to economic downturns and market volatility. These industries and companies provide essential goods and services that are in constant demand. This comes regardless of the state of the economy.,0.090899,Neutral,161.33,162.75,162.82,161.15,6415068.0,71762.0,162.417877
2023-02-14,Johnson & Johnson to Participate in the Barclays Global HealthCare Conference,https://investingnews.com/johnson-johnson-to-participate-in-the-barclays-global-healthcare-conference/,"Johnson & Johnson ( NYSE: JNJ ) will participate in the Barclays Global HealthCare Conference on Tuesday, March 14 th , at the Loews Miami Beach Hotel, Miami Beach, Florida.",0.276988,Somewhat-Bullish,162.74,162.04,162.9699,161.76,6317578.0,82242.0,162.287157
2023-02-15,JNJ Terminates NASH Program Pact With Arrowhead Pharmaceuticals - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/general/biotech/23/02/30926495/jnj-terminates-nash-program-pact-with-arrowhead-pharmaceuticals,"Arrowhead Pharmaceuticals Inc ARWR received written notice from Janssen, a unit of Johnson & Johnson JNJ, to terminate their rights to JNJ-75220795, now called ARO-PNPLA3, under the October 2018 research collaboration and option agreement.",-0.044716,Neutral,161.95,159.37,161.98,159.29,12635484.0,138511.0,160.193789
2023-02-16,EXL earns gold medal rating for sustainability efforts by EcoVadis,https://www.globenewswire.com/news-release/2023/02/16/2609791/9060/en/EXL-earns-gold-medal-rating-for-sustainability-efforts-by-EcoVadis.html,"NEW YORK, Feb. 16, 2023 ( GLOBE NEWSWIRE ) -- EXL [NASDAQ: EXLS], a leading data analytics and digital operations and solutions company, announced that it has been awarded a gold medal sustainability rating from EcoVadis, the leading assessment platform for environmental, social, and ethical ...",0.322334,Somewhat-Bullish,159.075,158.24,159.65,157.92,11179991.0,136994.0,158.680617
2023-02-17,Bladder Cancer Drugs Global Market Report 2023,https://www.prnewswire.com/news-releases/bladder-cancer-drugs-global-market-report-2023-301749125.html,"NEW YORK, Feb. 17, 2023 /PRNewswire/ --Major players in the bladder cancer drugs market are Pfizer, Celgene Corporation, Eli Lilly, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Sanofi, Hoffmann-La Roche, Novartis International and Johnson & Johnson.",-0.176834,Somewhat-Bearish,157.02,160.39,161.11,156.62,12401926.0,133424.0,159.568253
2023-02-21,US Supreme Court Refuses To Reject $302M Judgment Against Johnson & Johnson Over Pelvic Mesh Marketing - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/news/large-cap/23/02/30992505/us-supreme-court-refuses-to-reject-302m-judgment-against-johnson-johnson-over-pelvic-mesh-marketin,"The U.S. Supreme Court refused to hear Johnson & Johnson's JNJ regarding a $302 million judgment in a lawsuit brought by California, accusing the company of concealing the risks of its pelvic mesh products.",-0.324183,Somewhat-Bearish,159.65,158.0,160.35,157.89,9424439.0,131467.0,158.504163
2023-02-22,Genmab Publishes 2022 Annual Report,https://www.globenewswire.com/news-release/2023/02/22/2613531/0/en/Genmab-Publishes-2022-Annual-Report.html,Company Announcement ...,0.113161,Neutral,158.5,157.78,158.85,157.37,9820749.0,101149.0,157.956811
2023-02-23,JNJ: 3 Surefire Stocks You Can Buy Right Now,https://stocknews.com/news/jnj-caj-forr-3-surefire-stocks-you-can-buy-right-now/,"Amid the current volatile macroeconomic situation, we suggest considering surefire stocks of financially resilient companies such as Johnson & Johnson ( JNJ ) , Canon Inc. ( CAJ ) , and Forrester Research, Inc. ( FORR ) . Let's delve deeper to understand why these stocks could rack up significant ...",0.202391,Somewhat-Bullish,157.71,157.73,158.585,156.67,9385396.0,88704.0,157.624145
2023-02-24,Is Abbott Stock A Better Pick Over This Pharmaceuticals Bellwether?,https://www.forbes.com/sites/greatspeculations/2023/02/24/is-abbott-stock-a-better-pick-over-this-pharmaceuticals-bellwether/,Both stocks are trading at a similar valuation of a little over 4x trailing revenues.,0.193616,Somewhat-Bullish,156.65,155.97,156.85,155.21,8689726.0,101883.0,155.910179
2023-02-27,2 Forever Stocks to Buy and Hold for Long-Term Growth,https://www.fool.com/investing/2023/02/27/2-forever-stocks-buy-and-hold-for-long-term-growth/,They'll both be paying out dividends to shareholders for many years to come.,0.271731,Somewhat-Bullish,156.45,155.63,156.9,155.08,7267474.0,92284.0,155.801075
2023-02-28,JNJ: 3 Stocks to Help Grow Your Portfolio Over the Next Decade,https://stocknews.com/news/jnj-agco-ta-gs-bac-abmd-3-stocks-to-help-grow-your-portfolio-over-the-next/,"With ongoing mania regarding the Fed's stance on monetary policy, this year's early rally seems to be fading out. While positive economic data depicts the economy's resilience, surprisingly high inflation has renewed fears of the Fed's potential interest rate hikes in the coming months.",0.281169,Somewhat-Bullish,154.98,153.26,155.27,153.04,9063969.0,109333.0,153.714309
2023-03-01,V: 3 S&P 500 Stocks to Buy If You Like Winning,https://stocknews.com/news/v-jnj-mrk-gs-abmd-imgo-3-sp-500-stocks-to-buy-if-you-like-winning/,"Stronger-than-expected economic data, including solid job growth and a robust labor market in January, shows that the economy remains resilient, despite the Fed's interest rate hikes. After producing one of its worst returns in history last year, the S&P 500 could rebound sharply this year amid ...",0.263939,Somewhat-Bullish,153.01,152.57,153.24,151.91,6767649.0,98065.0,152.415802
2023-03-02,JNJ: 2 No-Brainer Warren Buffett Stocks to Buy in 2023,https://stocknews.com/news/jnj-mck-abmd-brk-a-brk-b-2-no-brainer-warren-buffett-stocks-to-buy-in-2023/,JNJ: 2 No-Brainer Warren Buffett Stocks to Buy in ...,0.241929,Somewhat-Bullish,151.75,152.45,152.76,151.231,8765385.0,102613.0,152.102754
2023-03-03,Tissue Expanders Market is Expected to Generate $1.18 Billion by 2031: Allied Market Research,https://www.benzinga.com/pressreleases/23/03/g31194227/tissue-expanders-market-is-expected-to-generate-1-18-billion-by-2031-allied-market-research,"Portland, OR, March 03, 2023 ( GLOBE NEWSWIRE ) -- According to the report published by Allied Market Research, the global Tissue Expanders Market garnered $671.5 million in 2021, and is estimated to generate $1.18 billion by 2031, manifesting a CAGR of 5.8% from 2022 to 2031.",0.247885,Somewhat-Bullish,153.37,154.02,154.12,152.84,5747158.0,83377.0,153.565779
2023-03-06,Bristol Myers  ( BMY )  Gets EU Nod for Anemia Drug Reblozyl,https://www.zacks.com/stock/news/2062273/bristol-myers-bmy-gets-eu-nod-for-anemia-drug-reblozyl,"Bristol Myers Squibb (BMY) gets full marketing authorization from the European Commission, for Reblozyl for anemia associated with non-transfusion-dependent beta thalassemia treatment drug in adult patients.",0.071107,Neutral,154.66,155.56,155.73,154.565,8148866.0,99253.0,155.388677
2023-03-07,Why Protagonist Therapeutics  ( PTGX )  Shares Are Trading Higher Today - Protagonist Therapeutics  ( NASDAQ:PTGX ) ,https://www.benzinga.com/general/biotech/23/03/31239091/why-protagonist-therapeutics-shares-are-trading-higher-today,"Protagonist Therapeutics Inc PTGX announced topline results from its collaboration with Janssen Biotech Inc, a part of Johnson & Johnson JNJ, in the FRONTIER 1 Phase 2b trial of oral Interleukin-23 receptor ( IL-23R ) antagonist peptide JNJ-2113 in patients with moderate-to-severe plaque ...",0.141016,Neutral,156.09,154.09,156.25,153.35,7458041.0,101723.0,154.324232
2023-03-08,Protagonist Therapeutics  ( PTGX )  Soars 51.9%: Is Further Upside Left in the Stock?,https://www.zacks.com/stock/news/2063013/protagonist-therapeutics-ptgx-soars-519-is-further-upside-left-in-the-stock,Protagonist Therapeutics (PTGX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.,0.206288,Somewhat-Bullish,153.98,152.96,154.1955,152.48,6230844.0,84884.0,153.030712
2023-03-09,"Biotech Stock Roundup: PTGX Gains on Study Data, BMRN Faces Setback & More",https://www.zacks.com/stock/news/2063653/biotech-stock-roundup-ptgx-gains-on-study-data-bmrn-faces-setback-more,Pipeline and regulatory updates from Protagonist (PTGX) and BioMarin (BMRN) are the key highlights from the biotech sector during the past week.,0.105654,Neutral,153.46,151.24,153.6,150.71,7439888.0,100651.0,151.698955
2023-03-10,JNJ: 2 Stocks That'll Help You Keep Money in Your Pockets,https://stocknews.com/news/jnj-pfe-bac-2-stocks-thatll-help-you-keep-money-in-your-pockets/,The early-year market rally lost its steam gradually owing to the inpouring of hotter-than-anticipated macroeconomic data. The Fed's hawkish comments further aggravated the already existing investor anxieties.,0.09297,Neutral,151.86,151.61,153.49,151.1,8504316.0,116900.0,151.985183
2023-03-13,JNJ: This Big Pharma Stock Is a Clear Buy in 2023,https://stocknews.com/news/jnj-nvo-bmy-nvs-abmd-this-big-pharma-stock-is-a-clear-buy-in-2023/,JNJ: This Big Pharma Stock Is a Clear Buy in ...,0.273657,Somewhat-Bullish,152.09,153.06,155.91,151.57,10799764.0,134679.0,154.091591
2023-03-14,"Global Antiviral Therapies Market Predicted to Generate a Revenue of $66,016.5 Million, Growing at a CAGR of 3.1% over the 2020-2027 Timeframe [208-Pages] | Explicated by Research Dive",https://www.benzinga.com/pressreleases/23/03/g31339569/global-antiviral-therapies-market-predicted-to-generate-a-revenue-of-66-016-5-million-growing-at-a,"New York, USA, March 14, 2023 ( GLOBE NEWSWIRE ) -- According to a report published by Research Dive, the global antiviral therapies market is projected to garner a revenue of $66,016.5 million and rise at a CAGR of 3.1% throughout the estimated period from 2020 to 2027.",0.221134,Somewhat-Bullish,153.28,153.92,154.03,151.9,8422204.0,94131.0,153.23992
2023-03-15,Are You Looking for a High-Growth Dividend Stock?,https://www.zacks.com/stock/news/2066215/are-you-looking-for-a-high-growth-dividend-stock,"Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Johnson & Johnson (JNJ) have what it takes? Let's find out.",0.388767,Bullish,152.84,154.35,154.89,152.5259,7758787.0,93973.0,153.955394
2023-03-16,VIG: 1 Dividend ETF to Buy Amid Uncertain Market Conditions,https://stocknews.com/news/vig-moat-qyld-gs-1-dividend-etf-to-buy-amid-uncertain-market-conditions/,"While consumer prices eased slightly in February, the stubborn inflation and tight job market could compel the Fed to raise interest rates. This and the recent turmoil in the banking sector could keep the stock market under pressure.",0.231831,Somewhat-Bullish,153.45,154.03,154.365,152.605,7606079.0,94834.0,153.764219
2023-03-17,"Top Stock Reports for Johnson & Johnson, Toyota Motor & Infosys",https://www.zacks.com/research-daily/2067318/top-stock-reports-for-johnson-johnson-toyota-motor-infosys,"Today's Research Daily features new research reports on 16 major stocks, including Johnson & Johnson (JNJ), Toyota Motor Corporation (TM) and Infosys Limited (INFY).",0.072864,Neutral,154.48,152.38,154.9499,152.3,20486358.0,105963.0,152.967583
2023-03-20,"SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Fate Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - FATE - Fate Therapeutics  ( NASDAQ:FATE ) ",https://www.benzinga.com/pressreleases/23/03/g31424897/shareholder-alert-pomerantz-law-firm-reminds-shareholders-with-losses-on-their-investment-in-fate-,"NEW YORK, March 20, 2023 ( GLOBE NEWSWIRE ) -- Pomerantz LLP announces that a class action lawsuit has been filed against certain officers and directors of Fate Therapeutics, Inc. ( ""Fate"" or the ""Company"" ) FATE. The class action, filed in the United States District Court for the Southern ...",0.069902,Neutral,152.47,153.89,154.075,152.38,7129115.0,84009.0,153.472136
2023-03-21,JNJ: Want to Retire a Millionaire? 2 Stocks to Buy Now,https://stocknews.com/news/jnj-pfe-abmd-want-to-retire-a-millionaire-2-stocks-to-buy-now/,"Concerns over the Fed's tighter monetary policy and the banking crisis will likely tip the economy into a recession. However, that should not deter investors from investing in quality stocks Johnson & Johnson ( JNJ ) and Pfizer Inc. ( PFE ) , which could help retire a millionaire.",0.195946,Somewhat-Bullish,154.0,153.89,154.13,152.17,8378492.0,100209.0,153.363563
2023-03-22,Looking At Johnson & Johnson's Recent Unusual Options Activity - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/markets/options/23/03/31460535/looking-at-johnson-johnsons-recent-unusual-options-activity,"Someone with a lot of money to spend has taken a bullish stance on Johnson & Johnson JNJ. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",0.189443,Somewhat-Bullish,153.85,151.05,154.06,151.03,7944548.0,105394.0,152.434634
2023-03-23,J&J Loses Key Tuberculosis Drug Patent In India,https://www.barrons.com/news/j-j-loses-key-tuberculosis-drug-patent-in-india-f83f3333,"India's Patent Office rejected on Thursday US pharmaceutical giant Johnson and Johnson's application to extend its patent on a key tuberculosis treatment, allowing local companies to make cheaper generic versions.",0.040849,Neutral,151.175,151.13,151.69,150.11,9051510.0,112579.0,151.050579
2023-03-24,2 Dow Stocks To Watch Today,https://stockmarket.com/featured/2-dow-stocks-to-watch-today-2023-03-24,"The Dow Jones Industrial Average ( DJIA ) is one of the world's most popular stock market indices. It is made up of 30 large-cap blue-chip companies that are industry leaders in their respective fields. These businesses were chosen for their reputation, growth potential, and overall financial ...",0.234067,Somewhat-Bullish,151.48,152.65,152.76,150.83,5624247.0,78996.0,152.089178
2023-03-27,"Inflation, TikTok, and Other Hot Stories Investors Are Talking About",https://www.fool.com/investing/2023/03/27/inflation-tiktok-and-other-hot-stories-investors-a/,"We've also got the latest in automotive, homebuilding, and the war on cash.",0.082199,Neutral,154.2,153.3,154.54,153.11,6772282.0,71142.0,153.475795
2023-03-28,Could This Drug Candidate Be a Winner for These 2 Big Pharma Stocks?,https://www.fool.com/investing/2023/03/28/could-this-drug-candidate-be-a-winner-for-these-2/,These titans of big pharma just enrolled patients into phase 3 clinical trials for this promising blood thinner.,0.060437,Neutral,152.39,151.82,153.45,151.725,6075048.0,76930.0,152.357907
2023-03-29,J&J backs out of RSV vaccine race with rivals Pfizer and GSK,https://www.cnbc.com/2023/03/29/jj-backs-out-of-rsv-vaccine-race-with-rivals-pfizer-and-gsk-.html,"J&J lagged behind rival drugmakers Pfizer and GSK, both of which made major strides toward U.S. approval of their RSV vaccines in the last month.",-0.07084,Neutral,152.24,153.31,153.38,152.07,6012251.0,81188.0,153.010604
2023-03-30,Why Is Fate Therapeutics  ( FATE )  Down 8.9% Since Last Earnings Report?,https://www.zacks.com/stock/news/2072512/why-is-fate-therapeutics-fate-down-89-since-last-earnings-report,Fate Therapeutics (FATE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.,0.063855,Neutral,153.58,153.43,153.8,152.81,4555905.0,71516.0,153.247222
2023-03-31,Johnson & Johnson  ( JNJ )  Could Be a Great Choice,https://www.zacks.com/stock/news/2073104/johnson-johnson-jnj-could-be-a-great-choice,"Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Johnson & Johnson (JNJ) have what it takes? Let's find out.",0.399761,Bullish,153.79,155.0,155.19,153.24,9843817.0,92896.0,154.546107
2023-04-03,Novartis  ( NVS )  Gets CHMP Positive Opinion for Entresto Approval,https://www.zacks.com/stock/news/2073837/novartis-nvs-gets-chmp-positive-opinion-for-entresto-approval,Novartis (NVS) receives a positive opinion from the CHMP for Entresto (sacubitril/valsartan) for a new indication in pediatric patients.,0.17695,Somewhat-Bullish,154.95,156.85,157.01,153.94,6842351.0,88544.0,156.380673
2023-04-04,Oncternal  ( ONCT )  Down on Restructuring Plan to Extend Runway,https://www.zacks.com/stock/news/2074388/oncternal-onct-down-on-restructuring-plan-to-extend-runway,Oncternal (ONCT) closes the development program for zilovertamab to extend its cash runway into 2025. Shares are down on the same.,0.019148,Neutral,156.97,158.49,158.97,156.59,8314527.0,119681.0,158.730696
2023-04-05,Club meeting recap: Jim Cramer says 'the existential threat is gone for J&J',https://www.cnbc.com/2023/04/05/jim-cramer-says-the-existential-threat-is-gone-for-jj-.html,"The Investing Club holds its ""Morning Meeting"" every weekday at 10:20 a.m. ET.",0.10456,Neutral,164.37,165.61,165.66,162.76,16661729.0,211344.0,164.282436
2023-04-06,Will Bristol Myers  ( BMY )  Gain From New Drugs' Label Expansion?,https://www.zacks.com/stock/news/2075733/will-bristol-myers-bmy-gain-from-new-drugs-label-expansion,Label expansion of Bristol Myers' (BMY) new drugs should help it somewhat combat the decline in Revlimid sales due to generic competition.,0.247791,Somewhat-Bullish,165.99,165.15,167.23,164.8,9615407.0,131320.0,165.499697
2023-04-10,Raydiant Launches Task Management Feature on Employee Experience  ( EX )  Platform to Better Engage Brick-and-Mortar Workers,https://www.prnewswire.com/news-releases/raydiant-launches-task-management-feature-on-employee-experience-ex-platform-to-better-engage-brick-and-mortar-workers-301793367.html,Raydiant Launches Task Management Feature on Employee ... PR ...,0.305049,Somewhat-Bullish,164.63,164.32,164.84,163.64,5355035.0,85473.0,164.157775
2023-04-11,Club meeting recap: Jim Cramer says stick with health care stocks in uncertain times,https://www.cnbc.com/2023/04/11/club-meeting-recap-jim-cramer-says-stick-with-health-care-stocks.html,"The Investing Club holds its ""Morning Meeting"" every weekday at 10:20 a.m. ET.",0.222786,Somewhat-Bullish,164.42,164.27,165.28,164.0401,5903921.0,83381.0,164.590824
2023-04-12,Check Out What Whales Are Doing With JNJ - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/markets/options/23/04/31769989/check-out-what-whales-are-doing-with-jnj,"Someone with a lot of money to spend has taken a bullish stance on Johnson & Johnson JNJ. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",0.189212,Somewhat-Bullish,163.94,163.92,164.84,163.1,5764354.0,79874.0,164.03702
2023-04-13,Don't Celebrate Yet: Lower Wholesale Inflation Data Mainly Reflected Drop in Energy Prices,https://www.benzinga.com/markets/23/04/31791322/dont-celebrate-yet-lower-wholesale-inflation-data-mainly-reflected-drop-in-energy-prices,"( Thursday market open ) More signs emerged early Thursday of cooler inflation, as the March Producer Price Index ( PPI ) fell 0.5%. It was the first monthly slide in PPI since December, and while it reflected a big drop in volatile energy prices, other areas also showed progress.",-0.082006,Neutral,164.18,166.11,166.33,163.805,5640617.0,78777.0,165.399027
2023-04-14,"Spencer Breithaupt Joins PetVivo Holdings, Inc. Board of Directors",https://www.globenewswire.com/news-release/2023/04/14/2647269/0/en/Spencer-Breithaupt-Joins-PetVivo-Holdings-Inc-Board-of-Directors.html,"MINNEAPOLIS, MN, US, April 14, 2023 ( GLOBE NEWSWIRE ) -- PetVivo Holdings, Inc. ( NASDAQ: PETV & PETVW ) ( the ""Company"" ) an emerging biomedical device company focused on the commercialization of innovative medical therapeutics for companion animals and animal athletes is pleased to announce ...",0.242534,Somewhat-Bullish,165.92,165.84,166.115,164.06,7084134.0,93858.0,165.310253
2023-04-17,"Club meeting recap: Cramer applauds Well Fargo's 'amazing' quarter, as the stock jumps",https://www.cnbc.com/2023/04/17/club-meeting-recap-cramer-applauds-well-fargos-amazing-quarter.html,"The Investing Club holds its ""Morning Meeting"" every weekday at 10:20 a.m. ET.",0.110636,Neutral,165.735,165.67,166.24,164.94,8048161.0,99799.0,165.540826
2023-04-18,Yet Again: Johnson & Johnson Subsidiary Seeks Stay On Thousands Of Cancer Lawsuits Associated With Talc Products - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/general/biotech/23/04/31860039/yet-again-johnson-johnson-subsidiary-seeks-stay-on-thousands-of-cancer-lawsuits-associated-with-t,"Johnson & Johnson's JNJ subsidiary, LTL Management, has reportedly requested a U.S. judge to delay 38,000 lawsuits again. These lawsuits accuse their baby powder and other talc products of causing cancer.",-0.256568,Somewhat-Bearish,164.25,161.01,164.69,159.65,14578822.0,196913.0,161.543626
2023-04-19,Why Shares of Legend Biotech Jumped Wednesday,https://www.fool.com/investing/2023/04/19/why-shares-of-legend-biotech-jumped-wednesday/,A leaked abstract on a phase 3 trial for the company's multiple myeloma drug Carvykti gave the stock a jolt.,0.038543,Neutral,161.99,162.53,162.68,161.17,6753287.0,95435.0,162.193339
2023-04-20,"Surging S&P 500 Breaks Above 4150 Threshold With Unprecedented Momentum, Driven By Strong Earnings And Economic Recovery",https://www.benzinga.com/23/04/31919329/surging-s-p-500-breaks-above-4150-threshold-with-unprecedented-momentum-driven-by-strong-earnings-an,"The S&P 500 has seen a 1.72% rise over the past week, with a promising start to the earnings season and potential for greater market returns. Major companies like Netflix, Nokia, American Express, and Johnson & Johnson have released earnings, with J&J beating expectations at $2.68 per share ...",0.195793,Somewhat-Bullish,162.43,163.58,163.82,160.96,9498668.0,118528.0,162.659239
2023-04-21,Alyssa Milano - Even Elmo - React To Elon Musk's Twitter Changes: 'We Are Officially Blue Check Mark Free',https://www.benzinga.com/general/entertainment/23/04/31937599/alyssa-milano-even-elmo-react-to-elon-musks-twitter-changes-we-are-officially-blue-check-ma,"Since taking over social media platform Twitter, new owner and CEO Elon Musk has put forth many changes. Among the biggest changes is the Twitter Blue subscription program, charging users to have their accounts verified. A change to the verification process happened on Thursday and many ...",-0.026536,Neutral,164.44,162.69,164.97,161.97,6889952.0,93399.0,163.06027
